POPULARITY
6 episodes with Okuda
4 episodes with Okuda
5 episodes with Okuda
3 episodes with Okuda
2 episodes with Okuda
2 episodes with Okuda
2 episodes with Okuda
2 episodes with Okuda
2 episodes with Okuda
Santander se encomienda al arte de Okuda para recuperar uno de sus edificios más emblemáticos. El artista cántabro ha presentado este viernes el proyecto del futuro Museo del Kolor. Una iniciativa cultural, artística y formativa que plantea devolver la vida al Palacio de Cortiguera tras décadas de abandono.
There are many treatment options for people with relapsing MS. Patients should be carefully monitored to assess treatment response, and a change in treatment approach should be considered if safety concerns emerge. In this episode, Teshamae Monteith, MD, FAAN, speaks with Ellen M. Mowry, MD, MCR, and Daniel Ontaneda, MD, PhD, coauthors of the article "Treatment of Multiple Sclerosis" in the Continuum® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Mowry is the director of the Multiple Sclerosis Experimental Therapeutics Program and a professor of neurology at The Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Ontaneda is the director of research at the Mellen Center for Multiple Sclerosis and a professor of neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Additional Resources Read the article: Treatment of Multiple Sclerosis Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Guest: @EllenMowryMD Full episode transcript available here Dr. Monteith: There are so many new treatment strategies for multiple sclerosis, which is a blessing, but it does come with the complexity of really just trying to nail down the approach. I just got finished talking to Drs Ellen Mowry and Daniel Ontaneda about their article on treatment of multiple sclerosis. We discussed relapses, weighing escalation versus early high-effective treatment and progressive disease. This is a must-listen-to podcast. I hope you enjoy it as much as I enjoyed talking to them. Dr. Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr. Monteith: This is Dr. Teshamae Monteith. Today, I'm interviewing Ds Ellen Mowry and Daniel Ontaneda about their article on treatment of multiple sclerosis, which they wrote with Dr. Darin Okuda. This article appears in the April 2026 Continuum issue on multiple sclerosis. Welcome, both of you. How are you? Dr. Mowry: Great. And thank you so much for having us. Dr. Monteith: Absolutely. So, why don't you both introduce yourself? Dr. Ontaneda: All right. My name is Daniel Ontaneda. I'm a neurologist at the Cleveland Clinic. I spend the majority of my time doing research, but I still dedicate about a day a week to seeing people with MS in clinic. Dr. Mowry: I'm Ellen Mowry. I'm also a neurologist, but practice at the Johns Hopkins University. And similar to Dan, I mostly work on research, but also have an active clinical care component, taking care of people with MS. Dr. Monteith: Well, thank both of you for writing this article and being on our podcast. I assume you guys have probably known each other for quite a while now. Dr. Mowry: Yes. Dr. Ontaneda: Yes. Dr. Monteith: What inspired you to get into multiple sclerosis research and then clinical care? Dr. Ontaneda: I always loved neurology, and I think a lot of us who go into neurology are attracted to the complexity of the human brain and how the nervous system works. But what really hit home to me was a family member of mine who had multiple sclerosis, and he was being treated in a time where we really didn't have super effective disease-modifying medications. And so, as I went through my medical career, I always kind of kept an eye on what was happening with multiple sclerosis, and I started my training at a time where it was really flourishing in terms of the medications available, so that's what inspired me to go into MS. It's a disease that we can definitely treat, and you can change outcomes for people. So, that was it. Dr. Monteith: Yeah, that personal experience can be very impactful. Dr. Mowry: My journey started, actually, because I was thinking about whether I wanted to be a physician at all, and I happened to land, just after high school, a position with a neurologist who happened to mostly focus on multiple sclerosis and taking care of folks with multiple sclerosis. And by the end of the summer, I knew I wanted to go to med school and I wanted to be a neurologist and I wanted to work with people with MS. I thought I would be a clinician exclusively, but I think as time went on and I started to hear the consistent questions that people I served were asking in the clinic and realizing that those questions could be turned into research projects that could address their concerns, I moved more and more towards research. Dr. Monteith: Great. There are a lot of really detailed information in the article, so I think that research mind is very useful, and I see that in the writing. Why don't we talk about the goal of the article? Dr. Ontaneda: So, I think the goal of the article was to set out kind of what the large view of what treatment for multiple sclerosis looks like. And, you know, many times we divide the treatment of multiple sclerosis into these large pillars, and I think that's what we did in the article. The first was, you know, what do you do with a person who has an MS attack or relapse? The second is, what medications do we use to treat the relapsing forms of multiple sclerosis where there is a lot of acute inflammation, focal inflammatory lesions that are occurring? And then the final one is, what do you do with individuals who have a more progressive form of the disease where they're accruing disability slowly and gradually? Dr. Monteith: And what were some of the main points? Dr. Mowry: Dr. Okuda provided a really nice section on the treatment of acute relapses in multiple sclerosis, and it's important to understand what we talk about when we are saying "relapse". For people with MS, many symptoms can fluctuate and occur and then get better over time, and sometimes people with MS use the same term of "relapse" to describe those symptom fluctuations. As neurologists, when we're thinking about relapse, we're really trying to think about symptoms that can be attributed to new focal inflammatory events somewhere in the central nervous system. Typically, these are accompanied---if you were to get an MRI at the same time---by a new lesion or MS spot, as I like to call them, on MRI scan. And so, it's important to distinguish when somebody is talking about symptoms, whether they are true new symptoms that could be mapped to a place in the central nervous system. Because alternatively, a lot of people who've had attacks or relapses in the past can have what we call pseudo-relapses, and these are essentially recrudescence of old symptoms, typically in a similar pattern as what had occurred in the past. And these can be brought out by things like fever or infection, sometimes stress. And pseudo-relapses are not thought to be due to new development of immune system-induced injury and therefore would be less likely to respond to treatment; and in fact, treatment may be contraindicated for those events. We also talked a little bit in that article about how relapses are treated, talking about the use of high-dose steroids for true new relapses, but also kind of cautioning that those are not necessarily free of concerns, especially if you have a pseudo-relapse or there could be an infection going on. And that ultimately, the decision as to whether to treat a relapse really is a shared decision-making because it's thought that although the steroids can speed up recovery from a relapse, they may not have a major impact on ultimate recovery. And so, a lot of the shared decision-making comes in here because for a mild relapse, you might choose to forego a course of high-dose steroids. Dr. Monteith: Daniel, any other main points? Dr. Ontaneda: Yeah. On the side of treating relapses, I think one of the other things that probably has changed a lot, at least during the course of my training, is that in the past, whenever we had identified a relapse, as Dr. Mowry has clearly defined, we would typically treat with intravenous high-dose corticosteroids, typically with methylprednisolone. And that was kind of our go-to. We would either do it in an infusion center or we would set it up with home care. And I think one of the things that our field learned over, I would say, the last five or ten years is there's an abundance of studies that show that you can give that same dose of methylprednisolone. Rather than giving it IV, you can give it orally. No pun intended, as I tell my patients, a lot of pills to swallow because we use fifty-milligram prednisone pills, and they have to take 1,250 a day. The pharmacy always pushes back on that many pills, but really the advantage of being able to take steroids orally that way for three to five days is really, I think, one, better for people with MS because they can do it in the comfort of their own home, and two, I think also when you look at the costs associated with that treatment, it is the most cost-effective option. Dr. Monteith: And what are some of the latest developments that you're really excited about that weren't in the article? Dr. Mowry: A lot of the article focused on the approach to treatment of people with what we've traditionally called relapsing/remitting multiple sclerosis. So, this is the kind of MS that traditionally presents with a relapse or an attack initially, although some of that nomenclature is changing, actually. And the article focused a lot on the strategies surrounding treatment of somebody with newly diagnosed relapsing MS, and thinking about this vast number of disease-modifying therapies that are available to people with MS and their clinicians, and how to think about the strategy with respect to largely centered around the efficacy class of the medication, whether people should take an approach of using a higher-efficacy therapy---meaning a medicine that in clinical trials was more likely on average to suppress relapses as well as new lesions---or whether there's still a good argument for the case of using an escalation approach, using some of the more modest efficacy medications that also probably in general have lower risks, monitoring for response to treatment and changing if the medication isn't working. And so, there's still a lot of debate in the field, I would say, even though many people have moved towards a one-size-fits-all kind of approach. I think there's still a lot of debate in the field about the evidence underlying that. And, you know, full disclosure, Dr. Ontaneda and I are each running parallel and very complementary clinical trial programs to address this very question, the results of which should be available within the next year, year and a half. Dr. Monteith: Well, we can't wait that long. Give me some clinical pearls to how we initiate these modifying therapies. Like, what are the pearls that we need to have in our mind? Dr. Ontaneda: Yeah. I think when we think about starting the disease-modifying therapy in an individual who has an active form of multiple sclerosis, I think, you know, one of the cornerstones I would say of making that decision is shared decision-making. I think we tend to sit down with the patient and analyze the data that we have at hand, what we know about their multiple sclerosis, and we use several factors to inform how likely we think their disease is gonna be active or potentially might not respond to the initial treatment you give. And we look heavily at the MRI. The MRI is really a useful marker because it shows us, one, how many lesions a person might have---both, you know, where those lesions are and also kind of the amount of lesions. Lesions, certainly, that are in the spinal cord, a very large burden of diseases. A lot of active lesions, which we determine by the presence of contrast-enhancing lesions, really helps us inform on disease severity. I would say that was our number one tool that we use to decide and help us decide how we think that person's MS is gonna do over time. And then the second thing that we put into the equation also is, you know, how well do we think this person is going to tolerate our medications? All our disease-modifying medications act through suppression of the immune system, and we know that that carries some risks associated with it. Some of those risks are stuff like infections. Some of those can be simple infections that really don't have major consequences, but some of them can be quite serious, including the need for hospitalizations or prolonged antibiotic treatment courses. And so, we also look at what, you know, the underlying risk of a person has for infection. This kind of is determined by, one, A, how many infections they've had up to date, and also how much disability they had. I would say in our average patient who when we see them, they're probably typically pretty young, in their twenties, thirties, forties, they typically don't have a lot of infectious risks. And therefore, I think there's kind of a move to saying, "Well, actually their risk of infections is quite low." And we put that together with, you know, also what the preference of the patient might want. So, do they prefer to take a pill, for example? Do they prefer a medication where they receive that via infusion every six months and they don't really have to think about it? There are some people that don't like going into a hospital, and they might prefer an injection type of those medications. And so, after a complex discussion of all those factors, we take into consideration how much risk the patient wants to take as well, and we come up with a rational choice of a couple of medication options. So, I think it's challenging sometimes because we have over two dozen medications. There's the risk of you saying, "There are these twenty-four medications, you can pick one." And I think our job as neurologists is to kind of pare those down, talk about, in a person like yourself, these are the two or three medications that I would recommend using. Why don't you review them? And then we bring them back, and we kind of make a final decision with, one of the key factors that I think is important to remind people is that you're gonna start this medication, and we are gonna monitor to make sure it's working. We're gonna monitor to make sure you're tolerating it well. And although it's an important, the first decision you make, I think one key theme that we tell people is, we can revise our strategy whenever we like. We just have to think about it and do it in a way that we think is gonna make sure that their MS is under the best control. And then we think about the ultimate goal of treatment, which, in multiple sclerosis, is the absence of any attacks and also the absence of any new lesions on MRI. And that's where whether you are offering more of the high-effective medications or more moderate- or low-efficacy medications, that's where there's a little bit of controversy still in our field, and that's what our trials are trying to answer. Dr. Monteith: Excellent. So now we've selected a particular option- and I love those points with shared decision-making, using the MRI to guide and then kind of risk tolerance related to infection. But now a patient's still having relapses, and I know the goal is zero, but, you know, there's some margin. What are the pearls to advance to more high-efficacy therapies? Dr. Mowry: Yeah, that's a great question. Dr. Ontaneda in the article actually talked about the literature surrounding monitoring for breakthrough disease and when to say this much is too much, and there's actually not a definite right answer. It's clear that more active disease early in the course is probably more of concern than, say, developing, you know, a new spot in your fifties or something to that effect. So, different people have different thresholds. I know at our center, we tend to be pretty on top of making changes for breakthrough disease. So, what we typically do is reimage people about six months after they start a medication to establish a new baseline. And sometimes, because of delays in starting or because the medications take a while to kick in, there might be a new spot or two. So, if that's the case, I really only get concerned if the spots are also taking up the dye or enhancing to indicate they're really quite recent, and I think, "Ugh, that's not something I'd like to see six months after starting a medication." And so that otherwise is sort of the reference scan, moving forward, to evaluate the medication, and I have a very low threshold for changing, particularly if somebody is on a moderate-efficacy therapy. To me, I think, well, our goal of trying the moderate efficacy therapy is essentially to see if we could get away with a medicine that is probably, on average, safer and that will still work for your MS. But if the answer is no, I personally don't like to stick around too much on them. One caveat I would say is that if somebody develops what appears to be a new lesion or spot on higher-efficacy therapy, before presuming that that new area of activity is a definite new MS event, I always like to rethink carefully, did I get the diagnosis correct? Or could this be an early infection such as, you know, progressive multifocal leukoencephalopathy in people on natalizumab in particular? Because I see breakthrough activity so rarely in people on higher-efficacy therapies that I just like to rethink my diagnosis and the differential prior to making switches to, typically, another higher-efficacy therapy in that case. But that, again, is a little bit of shared decision-making. It's sometimes contextual. If a person is using a self-administered medication and they have a little breakthrough, sometimes you can solicit some history, saying, "Oh, I actually kind of stopped taking it for a few weeks because something was going on, and I really want to retry." And that's very reasonable as well. Dan, do you have any other thoughts? Dr. Ontaneda: No, I think I agree. That's really close to how I practice myself as well, and the majority of people at my center. I think that we are learning that when you start a treatment, many times---depending on how deeply you look---you can find evidence of ongoing disease, and that's something that we struggle with. It's almost like we have tools to treat inflammation in terms of new MS lesions and new relapses. And so, when those are present, it's pretty clear that you probably have to switch medication. I think a slightly trickier issue is when, for example, you have a person who might be stable. They don't have an attack. But you notice that they're worsening, and they tell you they're worsening. I think our ability and tools for that is a little bit harder, and we recognize that that can actually happen fairly early in the disease. And that's why we're trying to rethink this mantra that we've had for many years, where we kind of divide MS up into relapsing and progressive, and we see people develop progressive MS 10 to 15 years after they've had a relapsing form of the disease. So, I think that's just a reality of clinical practice. And we don't have as many tools to treat that gradual worsening, which is kind of what the rest of our article spent some time talking about. Dr. Monteith: You've also written about the clinical trial long-term extension studies. And what are the few points that you take away from the emergence of these types of publications over the past few years? Dr. Mowry: Yeah, well, long-term extension studies can be really helpful to understand whether the findings that are evidenced during the randomized portion of trials themselves continue into a longer term. And for people with MS, understanding these data can be really helpful because, particularly when we're looking for impact of a given treatment or a strategy on disability worsening, often it takes longer than the short-term portion of the trial to truly understand if the medication or strategy has an impact on insidious worsening that Dan is speaking about. Many trials have demonstrated a short-term benefit, but we think a lot of times that benefit is probably because of the reduction in relapses, which sometimes leave a permanent mark on neurologic function. But the extension studies are trying to understand a little bit more about whether the effect on disability worsening is sustained, and also to look a little bit more deeply at long-term safety, especially when it comes to medications that do increase the risk of infection. The caveats, though, in interpreting those types of studies are that people drop out, and so probably the people who drop out of those studies are really different. They may be either less disabled and they think, "Oh, you know, I'm done. I feel good." Or potentially more disabled and they think, "Ugh, I have more things to do I've got to take care of. What's going on?" And so that kind of dropout can produce some bias in interpreting the results. Dan, any other thoughts? Dr. Ontaneda: No, I think that's spot on. I mean, I think that when we're trying to decide on what general philosophy to use, right? Like, you're seeing a patient for the first time. They've recently been diagnosed with MS, and you have... you know, I kind of bin them into three options. You can start a low-efficacy, a moderate, or a high-efficacy medication. And the first piece of information you could use is clinical trials, and Dr Mowry very clearly identified why some of that data might be a little bit biased and isn't, you know, completely applicable to the patient who's in front of you. The second thing that we might look at is observational data, and there's a wealth of observational data that shows that, in general, people on higher-efficacy medications tend to do better over time. But one of the challenges we have is that there's always biases related to those observational study designs. And so, I think you have to interpret them with a little bit of caution because there are reasons people start specific medications in people. And when you look at them in a purely observational study, even if you do some fancy way of addressing those biases, such as propensity, there always is the possibility of some residual bias. You know, that's part of the reason why we're doing the trials that Dr Mowry described, because we really need kind of long-term evidence to show that these medications actually can affect disability ten, twelve years after started. And I think pragmatic clinical trials, like the ones we're running, are really gonna be the key to answer those questions. We all have our favorite approaches right now, but I think that the data to actually demonstrate what's best for people with MS is really needed. Dr. Monteith: Great, and there's so much in this article. I mean, we didn't even touch on radiological isolated syndrome, monitoring MS therapeutically, and treatment of progressive MS. Any final take-home points? Dr. Ontaneda: Yeah. Maybe I will touch a little bit on the side of progressive MS, because it has been, you know, the MS that we historically have not been able to treat as much. So, we described there's over two dozen therapies approved for relapsing forms of MS. For purely progressive forms of MS that don't have any evidence of activity, we really only have one approved therapy, and it appears that that therapy actually does work through active inflammation anyway. And in the article, we highlighted examples of studies that have been negative, but also some recent examples of studies that have been positive, specifically with a new class of medication called BTKI, or Bruton tyrosine kinase inhibitors. We just recently heard of a second molecule that also had positive results in this realm. So, we're excited that, you know, in the next four to five years- Dr. Monteith: I'm sorry. Can you just go ahead and say what that molecule...You're leaving people hanging. Dr. Ontaneda: One molecule is tolebrutinib, which already has a positive study in secondary progressive MS in individuals without activity. And then the second compound that has been studied with positive trial results, we only have summary results from that, is a medication called fenobrutinib. And we think these two compounds that are part of a single class, the hope is that maybe they can address some of that gradual worsening that occurs in MS. And then the question comes whether we should use those from the get-go or if we should just use them later. So, a whole sort of variety of different questions. But I think important to call out for clinicians that this area where we had no available treatments for so many years might be changing. Dr. Monteith: Well, thank you both. I really loved this conversation. I learned a lot listening to both of you, and I look forward to your clinical trial results. Dr. Mowry: Thank you so much for having us. Dr. Ontaneda: Thanks so much. It was our pleasure. Dr. Monteith: Again, today I've been interviewing Doctors Ellen Mowry and Daniel Ontaneda about their article on treatment of multiple sclerosis, which they wrote with Dr. Darin Okuda. This article appears in the April 2026 Continuum issue on multiple sclerosis. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr. Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.
Nos trasladamos hasta el madrileño barrio de Usera para unirnos a la celebración de Okuda San Miguel o, simplemente, Okuda. Lleva 30 años desplegando su arte por todo el mundo y es considerado el artista urbano más importante de nuestro país. Hay obras suyas en Toronto, en Moscú, en Kiev o en París.
Kazの妻のYumikoをゲストに招待して、誕生日と夏の日本一時帰国について話しました。ご意見・ご感想など、お便りはこちらの Google Form で募集しています。メールアドレス london-tech-talk@proton.me にもお便りを送ってください。
Billy sits down with composer Logyn Okuda, who writes scores for some the world’s biggest box office hits, plus singer Josh Groban kicks off his world tour in Honolulu this weekend. But first, catch up with Saint Louis graduate Taʻimua Hannemann, who stars as Mr. James Dickley in the Oscar-nominated satirical short film, “Jane Austen’s Period Drama.”
Last time we spoke about the second Russian Counter Offensive over the Heights. Night operations opened the action: scouts moved in darkness, wires were cut, and Hill 52 fell before dawn, followed by Shachaofeng as dawn pressed the front. The Russians responded with a heavy counterattack, tanks, aircraft, and sustained artillery, yet the Japanese adapted quickly, shifting guns and reinforcing sectors to hold the crest. By 3–5 August, Japanese and Soviet forces fought in a fragmented front across multiple sectors: Hill 52, Changkufeng, Shachaofeng, the lake. Japanese commanders coordinated between infantry, engineers, and mountain artillery, while seeking long-range support from Kwantung Army. Soviet artillery sought to disrupt lines of communication and press from the Crestline with massed tanks and air strikes. Despite intense bombardments and repeated tank assaults, Japanese regimental guns, antitank teams, and close-quarters defense bore the brunt of the defense, inflicting heavy Soviet losses. Yet in the end the Japanese had yet again repelled the enemy from the heights. #183 The end was near for Changkufeng Welcome to the Fall and Rise of China Podcast, I am your dutiful host Craig Watson. But, before we start I want to also remind you this podcast is only made possible through the efforts of Kings and Generals over at Youtube. Perhaps you want to learn more about the history of Asia? Kings and Generals have an assortment of episodes on history of asia and much more so go give them a look over on Youtube. So please subscribe to Kings and Generals over at Youtube and to continue helping us produce this content please check out www.patreon.com/kingsandgenerals. If you are still hungry for some more history related content, over on my channel, the Pacific War Channel where I cover the history of China and Japan from the 19th century until the end of the Pacific War. While the front-line fighting raged on 6 August, Tokyo moved to supply the 19th Division with the coveted long-range artillery and antiaircraft support. In the evening, the Korea Army officially learned from the AGS that, by Imperial order, the Kwantung Army would add the strength already informally approved: four 7.5-centimeter field guns, two 15-centimeter cannons, two 10-centimeter railway guns, and two 7.5-centimeter antiaircraft guns. The North China Area Army would also provide mobile antiaircraft units. The Korea Army estimated that the field and heavy artillery reinforcements would reach the town of Tumen on 7–8 August. The new guns were expected to ease the division's pressure in due course. The fighting continued on the 7th. The 75th Infantry observed that, despite the Russians' vigorous attacks aimed at capturing Hill 52 and Changkufeng on 6 August, they failed at both objectives and were repelled with heavy losses. Because of the Soviets' ignominious defeat at Changkufeng, they seemed determined to seize Hill 52 on 7 August. Most of the shallow and isolated Japanese positions at Hill 52 had been shattered by bombardments. Some men retrieved Japanese corpses still piled atop one another; the wounded were to proceed to the rear by themselves. Many had not eaten since the morning of 6 August, yet morale remained high. It was decided to knock out the Soviets' advancing tanks under the cover of darkness, employing infantry and engineers. At 03:00, these elements moved against the armor 150 meters behind the Russian wire, killed some advancing infantry, and destroyed two tanks. The infantry platoon leader, Warrant Officer Kanaoka, jumped aboard a tank, pried open the turret, and fought with his blade as blood dripped from the blade. The eastern sky brightened as he stood there smiling and holding his bloodied sword; at that moment, Private First Class Kimura exploded a grenade inside the tank, which promptly blew up. The assault force returned safely at dawn. At dawn, from heavy-weapon positions 200–300 meters in front, the Soviets opened fire, exploiting gaps between the smashed armor. Since 04:00, sixty Russian tanks had been moving south on the far side of Khasan. By daybreak, more than ten machines could be seen in the dip northeast of Hill 52, with several dozen other tanks newly active along Hill 29 Crestline as infantry deployed in gullies. At 05:30, Russian artillery began firing from all directions. In addition to shelling from Gaho, Hill 29, and Maanshan, the Soviets directed flank fire against Hill 52, using two rapid-fire guns 700 meters northeast and three mountain guns on the slope of Changkufeng. As the works at Hill 52 were progressively pulverized, K. Sato dispatched reinforcements from the 76th Regiment there. Near 11:00, the Russian barrage intensified and became more accurate; positions were destroyed one by one, and casualties rose. A new apex of fury occurred between 13:30 and 14:30, when a pall of smoke blanketed the region, producing a ghastly impression. Russian planes bombed and strafed Hill 52 from 11:00; a raid by twelve bombers against the western slope at 13:30 was particularly fierce, though many bombs fell harmlessly into the Tumen. The Russian lines were built up gradually, and all types of Soviet weapons were employed. From 14:30, about 100 Russians approached, led by four tanks, and penetrated the defense positions. Close-quarter counterattacks were launched by elements of three Japanese infantry companies, a machine-gun platoon, and an engineer platoon. One officer recalled "It was tough and costly fighting. Men were overrun by tanks, some losing limbs." Nine engineers linked up with the infantry, placing explosives under tank turrets and blowing up two machines. During the crisis, with tanks and infantry overrunning his lines. From the right wing, in the Eleventh Company sector, the Japanese fought fiercely against Soviet heavy weapons and infantry who had advanced to point-blank range. Master Sergeant Suzuki, acting company commander, on his own initiative ordered the main force to counterattack. Through coordinated action, the Japanese knocked out four tanks that had penetrated their positions. Two enemy battalions that had "come close bravely" were nearly wiped out. Total Soviet strength committed in this sector amounted to three battalions and forty tanks. Japanese losses on the Hill 52 front were heavy indeed: seventy-four had been killed and eighty-five wounded, one hundred fifty-nine out of three hundred twenty-eight men in action. The remnants of one infantry company were commanded by a superior private; sergeants led two other infantry and two machine-gun companies. Seven of thirteen heavy weapons were inoperable. Meanwhile 9th Company elements defended Noguchi Hill, 800 meters southeast of Changkufeng. By 05:00 on 7 August, Soviet troops facing the hill numbered 200 infantry, five tanks, and two rapid-fire guns. From positions set up the previous night along the lake, the Russians opened fire at dawn while 50 soldiers moved to attack with the tanks in support. Captain Noguchi's men poured fire on the enemy and inflicted heavy losses. But the Russians, who possessed superior supporting fire, fought their way forward until, after 40 minutes, they got within 70 meters. The Soviet tanks disappeared into a dead angle near the lakeshore. When the fog lifted at 06:00, the Russians on the southeast slope of Changkufeng fired down at Noguchi Hill with four heavy machine guns. Seven tanks, advancing anew from the gully northeast of Hill 52, came as close as 80 to 200 meters, deployed to encircle, and opened fire. By now, eight Japanese had been killed and five wounded; most of the light machine guns and grenade dischargers had been crippled and all three heavy weapons were out of action. The Russians attacked again at 08:00, hurling grenades and shouting. A dozen tanks operated in support of two infantry companies. The Japanese responded with grenades; yellow and black smoke masked the heights, and the scene was extremely impressive. Desperate hand-to-hand combat raged along the sector for a half-hour until the Soviets fell back after suffering enormous losses. At 10:40, the Russians assaulted with infantry from the southeast front and from the Changkufeng direction, aided by tanks from the zone between. Captain Noguchi sortied with his remnant, charged the Russians, and drove them off. In this fighting, however, he was shot in the chest and most of his subordinates were killed or wounded. Somehow the captain stayed on his feet. He and six survivors threw grenades at the Russians, who were now behind the Japanese, and then he led a last charge back to the highest positions. Once the enemy had been evicted, Captain Noguchi collapsed. Only three or four soldiers were in fighting condition. The captain begged them to report to Sato, but, refusing to abandon him, the men managed to help him down to the rear. It was 11:30. Captain Noguchi's unit, which had fought bravely since the first combat on 6 August, had been destroyed. Of 78 officers and men, 40 lay killed and another 31 wounded. The hill had been lost. Meanwhile, Soviet bombardment of the Hill 52 district had been heavy, and phone contact with the regiment was severed. Suddenly, the indomitable Captain Noguchi appeared at headquarters, and the regiment finally learned that the foe had penetrated the defenses. The bleeding captain pleaded for a counterattack and kept trying to return to the fight; K. Sato had to restrain him by ordering him to leave for the rear. It was true that the position Captain Noguchi had occupied was the key point connecting Hill 52 and Changkufeng. But Sato reasoned that if they held solidly to the latter hills, their defenses would never be in danger, and it would be easy to retake Noguchi Hill at any time by concentrating fire from all the high ground and by employing artillery, once strength could be spared. Around sunset, however, Sato received an order from the brigade, and a report came from Changkufeng that "our troops' brave fighting has tied us over the crisis." Reassured, Sato proceeded to Hill 52, cheered on Kojima and the soldiers, and examined the condition of the wounded and the heaped-up corpses. The 75th Infantry estimated that there had been 900 Russian casualties in the right sector and that more than ten tanks and three heavy machine guns had been put out of action. The regiment itself had lost four officers killed and had four wounded. In the entire right sector which included 1,332 men in action, 140 had been killed and 180 wounded. Seven soldiers of the 75th Infantry were also listed as missing in action but presumed dead. Total casualties including the missing, as a percentage of those listed as engaged, amounted to 25 percent for the right sector unit. On the 7th, the unit had lost 19 machine guns and 11 grenade dischargers. As of 18:00 on 7 August, Japanese intelligence estimated that the Russians had committed a grand total of 25 infantry battalions, up six from 6 August, 80 artillery pieces, up 10, and 200 tanks . Situation maps showed one Soviet infantry battalion east of Changkufeng, another north of Hill 52, armor and infantry in unknown strength east of that hill, and artillery positions from northeast to southeast of Khasan. On the 7th, spotters also observed seven large steamers entering Posyet and Khansi, as well as one 10,000-ton vessel at Yangomudy. At least 200 or 300 enemy soldiers in the Karanchin sector were working to strengthen positions. Units moving south from Novokievsk included 350 trucks, 60 tanks, and 400 troops. Heading north from the region of the battlefield were 100 trucks and 150 horsemen. Meanwhile, on the front in eastern Manchuria, elements of the Kwantung Army's 8th Division had forcibly ousted a small party of Soviet border trespassers. The "punch" had gone out of the Russians in the Hill 52 sector after their thorough defeat on 6 and 7 August, but they continued to build up firepower, deploying heavy weapons and artillery observation posts. The bombardments grew more accurate; even regiment and brigade headquarters lost their last dead angles. By daylight on the 8th, two Soviet infantry battalions plus tanks were deployed on the Hill 52 front. Their main forces were distributed along a line 800 meters from the Japanese, and snipers and machine gunners held positions 200 to 300 meters away. "Each time they detected movement, they sniped at us and interfered with our observation." From 09:00, the Japanese sustained scattered artillery fire. At 13:30 there was a bombing raid by 15 planes, but no casualties were incurred. Soviet guns pounded Hill 52 around 18:30, and the Japanese suffered four or five casualties, but morale was generally high, and they sought to strengthen and repair their positions throughout the night. On the Changkufeng front, which had drawn rather serious attention, Russian heavy guns opened slow fire after 05:00 from east of Khasan and from Maanshan. Through the night of 7–8 August, Soviet infantry had assembled near the lake crossing. Russian troop strength increased beyond one-and-a-half battalions. The defenders ran out of grenades and had to resort to rocks, but by 10:00 the Soviet assault waves began to weaken after five hours of fierce resistance. Supporting the Japanese lines had been barrages by grenade launchers, flank fire by a heavy-machine-gun platoon at Chiangchunfeng, and supported by the mountain artillery. Around 10:30, the attackers fled to Khasan. The battlefield quieted, but enemy snipers dug foxholes 300 meters away and kept up persistent fire, and infantry mounted repeated attacks in varying strength. Since morning, the mountain gun and the two battalion guns at Fangchuanting had engaged infantry and machine guns that appeared on the middle of the Changkufeng crest as well as in the Hill 52 area. The timely fire from these guns caused severe losses, especially to Russian observation posts. But Lieutenant Maeoka, who commanded the mountain platoon from Changkufeng, was wounded badly at 10:30. The mountain battalion also fired at targets in the Changkufeng sector from the Korean side of the Tumen. At 13:20, the Russians pressed new attacks against Changkufeng from three sides, using a total of two companies and three tanks. Although they got close and attacked persistently, they were driven off each time; these afternoon efforts were not very vigorous. Fighters strafed at low altitude and more than ten bombers attacked near 15:00, igniting fires in the village of Fangchuanting. The raids by planes and guns caused frequent cuts in signal lines again. At 06:50 on the 8th, Soviet forces in the left sector resumed their efforts until they were pinned down at 100 meters and had to dig in. Excepting spotter posts, everyone must enter shelters from warning till all-clear. Meanwhile, T. Sato estimated that although enemy attacks were aimed mainly against Changkufeng, there existed some danger that hostile forces would cross the Tumen near Yangkuanping and launch a sudden attack against our left rear, as actions in that area had become pronounced. He accordingly issued an order at 17:00: all of us, superiors as well as subordinates, must overcome exhaustion, make nighttime guardings rigorous, and leave the foe not the slightest opening between friendly battalions or from the shores of the Tumen River. Suetaka estimated in the morning of the 8th that the Russians were trying to generate propaganda advantageous to them at home and abroad by staking their honor and seizing Changkufeng quickly. From the standpoint of overall political tactics, it was imperative to thwart their intentions. The enemy relied consistently on elements that remained on the Crestline southeast of Changkufeng and served as a base; they must be deprived of that attack base. If his assault plans were to be successful, the 37th Brigade would require reinforcement. The first battalion-size elements of Cho's infantry were arriving. As an initial step, Hanyu's battalion should cross the Tumen and join the brigade, while the main body of the regiment, due that afternoon, should be ready to enter the lines. The division chief of staff issued an order in the name of Suetaka, stipulating that the division would secure its positions while adhering to the great policy of nonexpansion. At 22:30 Morimoto speculated that the Russians were hoping for the good fortune of retaking Changkufeng. Strict guard measures were enjoined. Eventually, before midnight, Suetaka met Cho at Seikaku station. To implement Suetaka's request that the Russian foothold southeast of Changkufeng be wiped out soon, Morimoto decided in the morning to employ the new battalion from Cho's regiment. But since Hanyu's unit was delayed by enemy fire, Morimoto had to turn to the reserve 76th Regiment. At 16:00 Okido was told to prepare an attack, using one infantry battalion and an engineer squad. The mission was to take advantage of darkness to expel the foe remaining on Changkufeng, secure the heights in concert with the elements on the hill, and smash any serious attack at night. At 17:00 Okido issued his detailed order. Enemy elements were located near the cliff close to the northern top of Changkufeng. Apparently hostile bases existed in scattered fashion on the southern slopes as well, as well as a rather large base on the middle of Akahage "Red Bald" Hill, formerly held by Captain Noguchi's company. The regiment was to drive those forces north of Hill 52. The 3rd Battalion commander, Major Hashimoto Seishiro, was to direct both companies' assaults, and, once the foe had been ousted, secure the locations until dawn, after which he would return to the reserve unit. On the 8th, at 19:30, Hashimoto proceeded with his battalion staff to the foot of Changkufeng and conferred with Major Sato and Captain Shimomura, the majors commanding the units with which he was to cooperate. The assault units moved out from Chiangchunfeng, but their timing was thrown off by a half-hour of artillery checking fire from northeast of the lake. At 20:50, Captain Iwai's 10th Company, supported by a machine-gun platoon, attacked the rock corner on the east side of Changkufeng. After cutting down Soviet sentries, the Japanese rushed in; 40–50 Russian soldiers retreated toward Akahage. On that hill there had been only 20–30 Soviet troops to begin with, but their strength had been built up to two companies plus tanks and infantry guns. The Russians laid down violent small-arms fire, causing 17 Japanese casualties in a short period, after which 30–40 enemy soldiers sought to counterattack. The Japanese drove back this effort, readied their own offensive, and continued to launch close assaults against the heavy-machine-gun nest at the rock corner. Simultaneously, Captain Shidara's 7th Company jumped off with five attached demolition engineers. The 1st Platoon broke through the entanglements and cut down lookouts while the 2nd Platoon proceeded to mop up footholds on the north side—about ten Russian soldiers who dotted the slope at four locations. In the process, the company ran into the positions Iwai had been attacking. Terrain and enemy fire dictated a detour south of the ridgeline. Shidara's men moved up behind Iwai on the right, joining Hashimoto's command. The battalion commander consolidated his lines and directed reconnaissance preparatory to an attack against Akahage. Hours passed; Okido, at the command post, decided it might be wiser to wait till daybreak and call for artillery support. Hashimoto then issued his own instructions from the eastern salient, cautioning his men to dig in well. Near 04:00 the redeployments were completed, but construction did not progress due to the rocky terrain; soldiers were barely able to scoop knee-high firing trenches by daybreak. Total Russian losses on the 8th were estimated to exceed 1,500. More than 100 tanks were claimed publicly, and it was "confirmed" that since the 1st, six planes had been shot down, two of which had fallen behind Japanese lines. In Tokyo, the war ministry and the Gaimusho denied categorically that the Russians had retaken Changkufeng. Soviet troops had attempted to rush positions 600 feet from the crest at 1400 hours; after two and a half hours of furious hand-to-hand fighting, they were beaten off with presumably heavy casualties on both sides. Soviet tanks were reported moving north from Posyet Bay, though it remained unclear whether this indicated withdrawal or strategic movement. Right sector casualties were relatively light on 8 August: eight killed and 41 wounded, the 75th Infantry suffering five and 38 of these respectively. Officer casualties were proportionately high: two wounded in the 75th Regiment, one in the 76th Regiment, and a fourth in the mountain artillery. Personnel rosters of the 75th Regiment, as of 30 July and 8 August, showed a reduction from 1,403 to 826, down 41 percent. The cumulative effect of Japanese losses and the scale of Soviet commitment troubled the Korea Army. Suetaka reported Japanese casualties as: through 2 August, 45 killed, 120 wounded; from 3-5 August, 25 killed, 60 wounded; since 6 August, killed unknown, 200 wounded. Remarkably, the same casualty totals were released publicly by the war ministry on the night of the 8th. Throughout 9 August at 15:20 the Japanese were hit by a very intense barrage from Hill 29. The mountain gun was damaged by shellfire and had to be moved to the foot of Fangchuanting. Tanaka had ordered his artillery to conduct long-range artillery neutralization and communications-cutoff fire, and short-range neutralization as well as checking fire. The accuracy of our artillery elements had improved, and the power of our guns had been enhanced greatly. On the left, from 05:30, T. Sato dispatched an antitank platoon, under cover of mist, to finish off immobilized Soviet tanks whose main armament was still operational and which had done some severe firing the day before. As the day wore on, spirits rose, for the men heard the roar of friendly 15-cm cannon laying down mighty neutralization fire against enemy artillery. Near 14:15, Russian troops were detected creeping forward in the woods 400 meters away on the right. Supporting mountain artillery wiped out this threat in short order. Suetaka decided to move his division headquarters to Seikaku and his combat command post to the Matsu'otsuho message center. Anxiety about the Wuchiatzu sector to the north had diminished greatly; in addition, the entire strength of the division had already been brought to the front. Lastly, dealings with the Seoul and Tokyo levels had by now become rather secondary in importance. Suetaka could discern the steady, disturbing exhaustion of his front-line troops. On the other hand, newly arrived Cho was raring to go. After receiving authorization from Suetaka, Cho allowed Nakajima's battalion to cross the river at Matsu'otsuho but kept Osuga's battalion on the Korean bank as division reserve. Since Tanaka had surmised that the Russians' intention was to direct their main offensive effort against the Japanese right wing, it seemed best to transfer the mountain guns to strengthen the right sector positions. The brigade order of 17:30 endorsed Tanaka's shift of defensive emphasis, particularly with regard to the artillery and the new elements from Cho's regiment. Morimoto added that the core of the Soviet assault force southeast of Changkufeng amounted to two infantry battalions. T. Sato accordingly ordered Obo's battalion to integrate its heavy firepower and deliver swift fire in timely fashion. Soon afterward, Obo discerned a massed battalion of Russian infantry, who had been hauled up by trucks, on the northeastern skirt of Changkufeng. He unleashed every available weapon, organic and attached, at 19:30. The Soviets seemed taken completely by surprise; they showed extreme bewilderment and dispersed in an instant. The right sector unit estimated that on 9 August it had caused 450 casualties, stopped five tanks, and knocked out one light artillery piece and seven heavy machine guns. Japanese casualties in the right sector had amounted to 28 killed and 43 wounded. Ammunition expenditures were considerably higher than on the 8th. During the night of 9–10 August, the 74th Infantry reinforcements crossed the Tumen steadily. In the early hours, Okido concluded that Soviet attack designs had been frustrated for the time being. The Hill 52 front was relatively calm. Soviet automatic weapons and riflemen were still deployed 200 to 300 meters from Japanese positions, where they sniped selectively. Russian artillery was quiet, apparently as the result of the movement of the main Japanese artillery force to the right wing and the arrival of long-range guns. The 75th Regiment command post at Fangchuanting was the focal point of Japanese artillery activity. Firing began at 07:10, when four battalion guns engaged and smashed two Soviet mountain pieces. As for Soviet ground assaults, one company attacked at Changkufeng as early as 05:20 under cover of fog but was driven off after 40 minutes. The Russians struck again from three directions in formidable strength between 09:00 and 10:00. Morimoto, growing concerned about the danger of irruptions through gaps between Changkufeng and Shachaofeng, sent elements of Nakajima's battalion to Chiangchunfeng. Since the right wing of the Russians atop Changkufeng was spilling onto the western slopes, at 10:30 Nakajima had his heavy machine guns and battalion guns lay down strong fire from the peak of Chiangchunfeng. Meanwhile, heavy weapons from the left sector were also contributing to the repulse of the morning assaults. A battalion of Soviet infantry attacked Changkufeng all afternoon. Fierce gunfire by the 75th Regiment at 14:00 routed troops massing on the slopes facing the red flag. Considerable losses were inflicted on 75 Russians sighted northeast of Hill 52. An enemy company on the Khasan shore and another two east of Akahage Hill were attempting to occupy positions from which to strike Fangchuanting with the support of two rapid-fire guns. By 17:00 the Russians had been repulsed by the energetic fire of Japanese small arms, battalion guns, and artillery. Soviet forces dispersed toward the lakeshore and Hill 52, leaving many corpses behind. The last important firing by Japanese battalion guns at Fangchuanting on the 10th was a mission against the eastern slopes of Changkufeng at 18:00. Thereafter, the battle zone grew still. In the left sector, T. Sato concluded that, to secure Changkufeng, it would be best to reinforce flank fire instead of concentrating on the direct attack or defense of the Changkufeng district. He therefore made arrangements with Okido to borrow one machine-gun platoon and assign it to Obo. As of 05:30, enemy troops were still holding a line 300 meters from the positions of Obo's right battalion and 800 to 1,000 meters ahead of Takenouchi's left battalion. Shortly afterward, good news was received at the left sector command post: the last battalion of the 73rd Regiment was to have left Nanam at 16:00 on 9 August and would arrive in the near future. On the right wing of the left sector, the Russians facing Kadokura's company began to operate energetically from 09:00, advancing in two lines, 150 meters apart, with a total strength of one company: two platoons up, one platoon back. They were supported by forces on the high ground north of Khasan and on Akahage. Kadokura waited for the enemy to close to 200 meters before ordering his men to open fire; particularly effective was the flanking fire by the machine-gun company and by elements of Okuda's company. Many heavy artillery shells were hitting the Japanese lines now, but defensive fire pinned down the attacking infantry for a while, 100 meters from the breastworks. Then 30 or 40 Soviet soldiers, covered by firepower, worked forward as close as 30 meters, hurling grenades and giving every indication of mounting a charge. The Japanese responded with grenades. At the same time, the left-flank squad of Kadokura's company was being annihilated. Thus encouraged, Russian assault troops plunged close, whereupon Kadokura assembled his available men, a dozen or so, from the command teams and runners—and grappled with the foe at point-blank range. An ammunition man joined in the melee and broke up the Soviet assault by expert use of hand grenades. The second echelon gradually fell back around 10:30, in the face of heavy fire laid down by the machine guns and Okuda's company. The Russians appeared to be adjusting their deployment but made no further efforts to close. At Changkufeng, meanwhile, two or three enemy companies were approaching the crest. Left sector raiding fire caused the Russians to flee. Japanese casualties in the old right sector had been nine killed and 22 wounded on 10 August. It was estimated that Soviet casualties amounted to 600 killed or wounded, with five heavy machine guns knocked out. By this time, the Soviets had committed their maximum infantry and artillery strength: 27 battalions and 100 guns, the same as on 9 August but up 17 battalions and 60 units since 3 August. Higher headquarters reported no tanks at the front, though 75th Infantry situation maps indicated some Soviet armor still faced Hill 52 sector. Although Japanese officers insisted that Changkufeng Hill remained in Japanese possession, they acknowledged increased casualties due to the accuracy of Soviet shelling. Losses were not as severe as might have been expected because the enemy did not time their charges with their bombardments; Japanese troops lay in trenches and met the attackers with grenades. Every combat unit of the 19th Division had been committed. Nevertheless, the maimed and the fresh battalions had amounted to a combined maximum strength of only 12 infantry battalions and 37 artillery pieces, primarily 75-mm mountain guns, without armor or aircraft. These forces had to cope with 27 enemy infantry battalions and 100 artillery pieces, including many long-range guns, as well as sizable tank and aerial units. Every echelon, regiment, division, and army, had voiced the need for troop replacements and reinforcements. By evening of 10 August, the situation had deteriorated to the point that the division chief of staff sent Seoul a very long and painful message that ended with: "There is danger of radical change in combat situation in few days if matters go on. It is estimated that this division has only one or two days left in which it can retain definite freedom of action,initiative to advance or retreat. Even if overall situation should develop to our advantage in next three or four days, we ought to be patient from broader standpoint, and be satisfied with our achievement, that Japanese Army has manifested its strength against enemy till now. While we do retain freedom of action, it would be appropriate to solve incident now through speedy diplomatic negotiations. Such measures are entirely up to Korea Army and high command but, so far as division is concerned, there is no other way except of course to make desperate efforts to maintain occupation line for sake of mission. Please take these matters into sympathetic consideration and conduct appropriate measures urgently". I would like to take this time to remind you all that this podcast is only made possible through the efforts of Kings and Generals over at Youtube. Please go subscribe to Kings and Generals over at Youtube and to continue helping us produce this content please check out www.patreon.com/kingsandgenerals. If you are still hungry after that, give my personal channel a look over at The Pacific War Channel at Youtube, it would mean a lot to me. Night raids and artillery opened the fight, with Hill 52 and Changkufeng changing hands amid intense Soviet tank and air assaults. Japanese forces, aided by engineers, infantry, and mountain guns, mounted tenacious defense, repelling repeated Soviet breakthroughs though suffering heavy casualties. By August 10, Japanese divisions faced mounting exhaustion and warnings of potential strategic shifts, while both sides suffered substantial casualties and material losses.
00:13 – Intro & Lions/Eagles Misery Chris and Mario open from “on location,” joking about Uzbekistan, then dive into Lions and Eagles frustrations: injuries, failed physicals, underperforming CBs (Arnold, Okuda), tired defenses, Saquon's decline, O-line issues, and constant coordinator turnover. 09:56 – Coaching Personalities & Fit Discussion of Mike McDaniel, Lane Kiffin, Joe Judge, personality conflicts, and how coaches struggle when they aren't “the guy.” 13:56 – Recruiting, NIL & Transfer Portal Chaos Shifts to college football: strange QB commitments (Houston/Vanderbilt), Penn State's recruiting collapse, BYU coach leverage, loyalty vs. opting out, and Wrexham anecdotes about finishing seasons with teammates. NFL Week 14 Games 23:46 – Cowboys at Lions Debate over Detroit's ability to stop Dallas, injury concerns, and Lions' must-win stakes. 24:50 – Bengals at Bills Buffalo's inconsistency, Cincinnati's uneven form, and how each team's identity is shifting. 26:15 – Colts at Jaguars Conversation about both teams' surprising rise, T-Law's volatility, and AFC hierarchy questions. 27:18 – Dolphins at Jets Jets' cold-weather advantage, defensive competence, and Miami's road vulnerability. 29:07 – Saints at Buccaneers Tampa rediscovering rhythm, Saints' issues, and how injuries complicate both sides. 30:26 – Steelers at Ravens Baltimore's higher ceiling, Steelers' struggles, and roster decisions (Mark Andrews, Likely). 34:45 – Seahawks at Falcons Atlanta's offensive talent vs. collapse, QB uncertainty, and Seattle's playoff relevance. 37:23 – Titans at Browns Cam Ward soundbite, Tennessee's internal frustration, Cleveland's QB chaos, and fan unease. 45:42 – Commanders at Vikings Both teams' self-inflicted issues, run-game reliance, and thin margins. 46:10 – Broncos at Raiders Denver's need to “prove it,” Raiders' volatility, and why this matchup remains unpredictable. 48:15 – Bears at Packers Playoff-seeding implications, Chicago's surprising standing, and Green Bay skepticism. 50:41 – Rams at Cardinals Arizona fading post-elimination; Rams viewed as eye-test contenders. 51:14 – Texans at Chiefs Discussion of Kansas City's strange season, playoff positioning, and Houston's growth. 54:42 – Eagles at Chargers Herbert's health, Trey Lance possibilities, Eagles' defensive punch, and LA's underachievement.
“We are fans too.” Sistas Fran and Tamia sit down with legendary Star Trek designers Michael and Denise Okuda—the creative minds behind LCARS, iconic starship displays, and so much more. In this heartfelt conversation, the Okudas share how their love for Trek—and deep respect for its fans—inspired decades of groundbreaking design. They're not just part of Star Trek history—they're fans too. And they've always wanted to get it right for the biggest Trekkies of all. Follow Michael & Denise Okuda: https://www.facebook.com/Michael.Denise.Okuda/about_profile_transparency/ Check out: The Roddenberry Archive https://archive.x.io/about/ The Roddenberry Vault: https://memory-alpha.fandom.com/wiki/Star_Trek:_The_Original_Series_-_The_Roddenberry_Vault Associate Producers: Sailor Marj, Karen Dramera, and Stephanie Baker Thank you to Dena Massenburg for our dope logo: @blackbeanz70 Music: “Poppin off the Rip” Artist: RAGE Source: YouTube Audio Library SUPPORT US ON PATREON: https://www.patreon.com/syfysistas SUBSCRIBE > LIKE > SHARE: https://linktr.ee/syfysistas You can find the SyFy Sistas and our family of podcasts on The Trek Geeks Podcasts Network: https://trekgeeks.com FANSETS - Our pins... have character. Thank you to our friends at FanSets for being the presenting sponsor of the Trek Geeks Podcasts. Tune in to this episode to get an exclusive code and score 10% off your entire purchase! https://fansets.com STRANGER COMICS - THE BEST IN FANTASY COMICS! Tune in to this episode to get an exclusive code and score 10% off your entire purchase! http://www.strangercomics.com/
“We are fans too.” Sistas Fran and Tamia sit down with legendary Star Trek designers Michael and Denise Okuda—the creative minds behind LCARS, iconic starship displays, and so much more. In this heartfelt conversation, the Okudas share how their love for Trek—and deep respect for its fans—inspired decades of groundbreaking design. They're not just part of Star Trek history—they're fans too. And they've always wanted to get it right for the biggest Trekkies of all. Follow Michael & Denise Okuda: https://www.facebook.com/Michael.Denise.Okuda/about_profile_transparency/ Check out: The Roddenberry Archive https://archive.x.io/about/ The Roddenberry Vault: https://memory-alpha.fandom.com/wiki/Star_Trek:_The_Original_Series_-_The_Roddenberry_Vault Associate Producers: Sailor Marj, Karen Dramera, and Stephanie Baker Thank you to Dena Massenburg for our dope logo: @blackbeanz70 Music: “Poppin off the Rip” Artist: RAGE Source: YouTube Audio Library SUPPORT US ON PATREON: https://www.patreon.com/syfysistas SUBSCRIBE > LIKE > SHARE: https://linktr.ee/syfysistas You can find the SyFy Sistas and our family of podcasts on The Trek Geeks Podcasts Network: https://trekgeeks.com FANSETS - Our pins... have character. Thank you to our friends at FanSets for being the presenting sponsor of the Trek Geeks Podcasts. Tune in to this episode to get an exclusive code and score 10% off your entire purchase! https://fansets.com STRANGER COMICS - THE BEST IN FANTASY COMICS! Tune in to this episode to get an exclusive code and score 10% off your entire purchase! http://www.strangercomics.com/
Michael Okuda graduated from BYU with a bachelor's in statistics and works as a data analyst in Dallas. Growing up, he was a competitive pianist, where he was a three-time champion in the statewide Kentucky Music Teachers Association piano competition. His other hobbies include tennis, trying new restaurants, and line dancing.Michael loves getting to know people and is always curious about not only how they gather together but also connect. He was part of the first BYU belonging council to help create spiritual resources for BYU LGBTQ students.Michael is also career-driven. He will begin his master's in analytics through Georgia Tech and has aspirations to become a data scientist. He also has interests in personal finance, real estate, and workplace culture.Find and connect with Michael on IG: @michael_okuda____________________________Register for First Friday's Free coaching and learn other ways to work with me: https://paperbell.me/meagan-skidmorehttps://meaganskidmorecoaching.com.Please help the podcast grow by following, leaving a 5 star review on Spotify or Apple podcasts and sharing with friends.Living Beyond the Shadow of Doubt™ is a proud member of the Dialogue Podcast Network [DialogueJournal.com/podcasts].Hopeful Spaces, a monthly support group facilitated by Meagan Skidmore Coaching, is a Dallas Hope Charities component of Hopeful Discussions sponsored by Mercedes-Benz Financial Services USA. Send an email to chc@dallashopecharities.org to join.
En 1988 se estrenó 'Mujeres al borde de un ataque de nervios', de Pedro Almodóvar. Una de las películas más icónicas del cine español. Hablamos del largometraje con la que fue la directora de producción de esta película, Esther García, Premio Nacional de Cinematografía 2018. Ha sido directora de producción de más de noventa películas y es directora de Producción de 'El Deseo', de Pedro y Agustín Almodóvar. Al borde del acantilado del Cabo de Ajo en Cantabria se encuentra el que a día de hoy sigue siendo el único faro de España, que a su vez es una pieza de arte urbano: el faro de Ajo. Están a punto de cumplirse cinco años desde que las autoridades de Bareyo encargaron al artista Okuda. Hemos invitado a Jana Sánchez, compañera y redactora de Radio Santander, para que nos cuente la evolución de esta obra de arte. Este lunes, nos acompaña Alejandro Pelayo al piano de la SER.
En 1988 se estrenó 'Mujeres al borde de un ataque de nervios', de Pedro Almodóvar. Una de las películas más icónicas del cine español. Hablamos del largometraje con la que fue la directora de producción de esta película, Esther García, Premio Nacional de Cinematografía 2018. Ha sido directora de producción de más de noventa películas y es directora de Producción de 'El Deseo', de Pedro y Agustín Almodóvar. Al borde del acantilado del Cabo de Ajo en Cantabria se encuentra el que a día de hoy sigue siendo el único faro de España, que a su vez es una pieza de arte urbano: el faro de Ajo. Están a punto de cumplirse cinco años desde que las autoridades de Bareyo encargaron al artista Okuda. Hemos invitado a Jana Sánchez, compañera y redactora de Radio Santander, para que nos cuente la evolución de esta obra de arte. Este lunes, nos acompaña Alejandro Pelayo al piano de la SER.
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum. Dr. Darin Okuda is the Director of the Multiple Sclerosis and Neuroimmunology Imaging Program, the Director of Neuroinnovation, and the Deputy Director of the Multiple Sclerosis Program and Clinical Center for Multiple Sclerosis at University of Texas Southwestern Medical Center. At the ACTRIMS Forum, we talked with Dr. Okuda about the impact of artificial intelligence on MS care, how to go about preventing MS, and a frightening case study of what went wrong with an MS patient's generic disease-modifying therapy. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/actrims01 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS on YouTube https://www.youtube.com/@RealTalkMS Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Bonus Episode Guest: Dr. Darin Okuda Privacy Policy
Salimos a la calle para hacer un programa especial desde Factory of dreams, el taller de arte y también, lugar de exposiciones, del artista internacional Okuda San Miguel. El barrio de Usera, en Madrid, es el escenario donde hemos podido escuchar en directo la música de Azuleja y de Ona Mafalda. Además, Rigoberta Bandini y Carmen Lancho han presentado su nueva colaboración: 'Aprenderás', un adelanto del próximo disco de Rigoberta, que se titulará 'Jesucrista Superstar'. También, el productor Ed is Dead, que tiene su estudio dentro del taller de Okuda, nos ha mostrado las herramientas con las que trabaja su música y ha hecho partícipe al público que nos acompañaba. Por último, el propio Okuda y sus compañeros Nuria Mora y Sixe Paredes han debatido sobre arte en un espacio irrepetible.Escuchar audio
durée : 00:30:05 - " Awarerum ", Composition électroacoustique de Megumi Okuda - par : Anne Montaron - Dans nos brèves sonores cette semaine, cinq pièces électroacoustiques de la jeune compositrice Megumi Okuda élaborées à partir des sons d'une machine qu'elle a enregistrés, analysés, puis transformés avec les outils du studio. - réalisé par : Olivier Guérin
durée : 00:30:05 - " Awarerum ", Composition électroacoustique de Megumi Okuda - par : Anne Montaron - Dans nos brèves sonores cette semaine, cinq pièces électroacoustiques de la jeune compositrice Megumi Okuda élaborées à partir des sons d'une machine qu'elle a enregistrés, analysés, puis transformés avec les outils du studio. - réalisé par : Olivier Guérin
Entrevistam Okuda San Miguel, artista que pintarà el terra del carrer Santa Agnès del West End de Sant Antoni.
Enjoying a conversation with art chad supreme Bobby Mars. We talk about public art, particularly his awesome new piece about a ridiculous new mural to globalism recently erected in Saginaw, MI. Famous Spanish artist Okuda, who could not look more like the gay Riddler, received paid hundreds of thousands to paint Corporate Memphis over rust belt blight. You couldn't write a more perfect allegory.The Carousel is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Get full access to The Carousel at www.carousel.blog/subscribe
L'effet Buckaroo Banzai d'Entre ! Geek Ce podcast vous est offert par le Buckaroo Banzai Institute en collaboration avec le podcast “Entre ! Geek”, le podcast des oeuvres oubliées mais pas oubliables™.Il a été monté de mains de maitre par Babar, grand merci à luiAvant de lire ce long descriptif, ou écouter ce long podcast…n'oubliez pas que vous pouvez envoyer vos remarques à causmicbeast@gmx.fr (bafouille audio, écrite, signaux de fumée et mots doux, ou durs ….) Retour vers le passé, alors que toute la France et la Navarre se massait devant la lucarne magique pour une heureuse communion devant l'Eurovision, une équipe de podcasteurices chevronné.e.s (dont un chevrotant … wink wink) s'est retrouvé à deviser devant, je cite “un film écrit par un enfant hyperactif de 10 ans” (dixit Dany™).... roulement de tambours Les Aventures de Buckaroo Banzaï à travers la 8e dimension https://www.imdb.com/title/tt0086856/ et https://www.primevideo.com/-/fr/detail/Les-aventures-de-Buckaroo-Banza%C3%AF-%C3%A0-travers-la-huiti%C3%A8me-dimension/0PPCJAQTY5ZWIDDXM17F1LHBQ1 ● Tout d'abord Ak_dallas https://bsky.app/profile/akdallas.bsky.social, notre CAP en pop culture● Mais aussi, revenu de sa balade pour les “petits zurbains”, le seul, l'unique, le velu du menton Dany, le comptable chanteur de charme…. mais a t'on besoin de mettre ses références :)● Arrivé de la planète glaçon, cocktail et TN Network, Chris Yukigami, mixologue interstellaire https://x.com/ChrisYukigami , sans oublier sa belle aux yeux revolver Holly https://x.com/Sakadomc● Notre urgentiste, fan de roulade et amateur de musique qui fait des trous dans le c… euuuh cerveau, ceinture noire en https://www.sublimetext.com/ -fu, voici Babar https://x.com/BG_Babar !● Et enfin un certain CausmicBeast (qui continuera décidément )à parler de lui à la 3ème personne, allez comprendre (causmicbeast@gmx.fr) La bande annonce française histoire de vous mettre en bouche… ou à vous donner l'envie de prendre vos jambes à votre cou… https://youtu.be/ofvAi0psel4?si=es_6Cbw7Rsxu6SYDL'affiche américaine … d'une fadeur ultime https://en.wikipedia.org/wiki/The_Adventures_of_Buckaroo_Banzai_Across_the_8th_Dimension#/media/File:Adventures_of_buckaroo_banzai.jpg et celle francaise autrement plus classieuse https://cine-images.com/produit/les-aventures-de-buckaroo-banzai-a-travers-la-8eme-dimension réalisé par Melki https://www.melki.orgMême Nanarland en a perdu son latin, la preuve ici, https://www.nanarland.com/chroniques/aux-portes-du-nanar/au-dela-du-nanar/buckaroo-banzai.html … Un film qui est capable d'invoquer auprès des chroniqueurs d'Entre ! Geek le fantôme de Jairo (attention, respecter les posologies d'usage) https://youtu.be/YFKV13x3Ae4?si=3o7a8iBYNH5FWOCS … tout ça pendant la retransmission de l'Eurovision 2024, on y trouve le moyen de citer le maitre du Haut Chateau de Philippe K. Dick en roman https://fr.wikipedia.org/wiki/Le_Ma%C3%AEtre_du_Haut_Ch%C3%A2teau ou en série https://fr.wikipedia.org/wiki/Le_Ma%C3%AEtre_du_Haut_Ch%C3%A2teau_(s%C3%A9rie_t%C3%A9l%C3%A9vis%C3%A9e) mais aussi de faire des enfants illégitimes entre le Capitaine Flam https://www.youtube.com/watch?v=FQSDW57pnMY et un obscur film japonais de 1987 Earth Defense Girl Iko-chan https://archive.org/details/ikochan-2-plus-1Un Peter Weller beau comme un dieu… et qui accepte tout, bien avant Robocop https://youtu.be/IqvRDhW-XVA?si=4M_8k-g0Yg-ZWdAGEt vous, Billy Joel ???, teasons, teasons… (restez jusque la fin du podcast … si si) https://youtu.be/hCuMWrfXG4E?si=nsgPA6MnyIzKMn_qLa grande question qui restera toujours posée, CausmicBeast, prend t'il ses souvenirs pour des quiches lorraines… A til vu la bande annonce en 1984, en 1986 ? Était ce pendant Monsieur Cinéma ? https://youtu.be/EwlPR3i90y0?si=O9lmia-zELBdigul La séance du Téléspectateur ? https://youtu.be/t8Lsi7dEdTs?si=gI9EOqQUO_tK67r2 , mardi Cinéma ? Et spéciale dédicace à benracer85 https://x.com/benracer85 https://www.youtube.com/watch?v=EwlPR3i90y0&pp=ygURbW9uc2lldXIgY2luw6ltYSA%3DMémoire quand tu nous tiens :-/ (C'est moche de vieillir, hein Dany )Sans oublier de s'épancher sur un certain Howard The Duck, un film de gros C…anard ;) https://youtu.be/M2RNrmCJLtA?si=8XM_JET4KM48LK6o un vrai film inter espèce (wink wink)Aller plus loin que ce qu'on vous demande, à la manière de Buckaroo Banzai, Tom “Croisière” s'en est il inspiré https://youtu.be/NRD0DWhSYlY?si=y6OimMjlmtZ1WakA et de là à dire que la scène est presque identique… wink wink wink. Sans oublier le père de tous les films supersoniques avec des têtes brulées, “l'Etoffe des Héros” https://youtu.be/D9XcaE5bjkc?si=76nPMZBXTEB0d2ZMAh Salt Lake City, son lac salé et ses mormons en libertés… Et bien non, il est bien dit dans le film que c'est au Texas officiellement (désolé Dany … ) mais, en fait un lac asséché dans le désert du Mojave https://en.wikipedia.org/wiki/El_Mirage_Lake (dixit https://www.figmentfly.com/bb/movie3.html qui tient ses sources du Buckaroo Banzai Institute lui même).Vous aimez la quincaillerie : regardez la Jet car (et allez écouter le podcast que nous avons déjà fait avec Babar Et AK_Dallas à cette adresse https://entregeek.lepodcast.fr/entre-geek-quincailleries-des-annees-80 ou sinon, faites comme Dany, fantasmez sur une Volvo 240 https://youtu.be/dB_28VOxQoo?si=5UlH0FuJBr4K9BuX (on a les fantasmes qu'on peut, parait il !) mais au moins elle va loin !!! (AK_Dallas™)Un moment de pub … merci à Thomson (et Marouani) https://youtu.be/F8IgKbopttI?si=aV7lGVN3xXwq3ILpTrigger warning sur les tentatives de suicide : https://3114.fr/, un numéro pour en parler … et aussi la chanson dont parle Dany Billy Joel - You're Only Human (Second Wind) https://youtu.be/YhxjNYvJbgM?si=iLDpzO51pVbm01ImEt point New Brunswick, pas au Canada mais bien une ville du New Jersey (ouppppps une nouvelle fois) https://fr.wikipedia.org/wiki/New_Brunswick_(New_Jersey) Retour vers le futur du passé de Janvier 1986 (la sortie française de Buckaroo) . Merci AK_DallasVoici les liens, à vous d'écouter le podcast pour connaitre titres et interprètes● https://youtu.be/cVikZ8Oe_XA?si=wRL-Lr8jpGVFlnSS● https://youtu.be/SWtiCRntA-E?si=qgrTSWhCSNOnHcXm● https://youtu.be/Tg-Q-Acv4qs?si=3SlgwQ9MrgW7bc7I● https://youtu.be/4jjzu1Z2RZc?si=4lJf35qPG4qskZZI● https://youtu.be/6W0d9xMhZbo?si=Wj8efVJtvU4PYRXT Et si vous aimez les petites allemandes de Sarrebruck qui faisaient chavirer le coeur des p'tits mosellans …. https://youtu.be/4F9DxYhqmKw (mais chut, éloignez les enfants hein) et au fait … Sa Kumba ???? https://youtu.be/4F9DxYhqmKw Et pourquoi ne faut il pas laisser BB ((Buckaroo Banzai) dans un coin … parce qu'il est alimenté par le pulp (d'ailleurs une super conférence du https://campusmiskatonic.fr/ https://www.youtube.com/live/hFvM2XbbepI?si=vddPcJ6Lcr_MbzDh) pour en apprendre plus sur cette production à bas prix … Buckaroo Banzai est-il le fils illégitime de Doc Savage ? https://fr.wikipedia.org/wiki/Doc_Savage , mais aussi des sérials https://www.youtube.com/@jefferymccann6467 … sans oublier la tentative De Laurentis de faire Flllllllaaaaaassssssssshhhhhhhaahahahhahahahahahha en 1980 https://youtu.be/LfmrHTdXgK4?si=ilQ2iuSKAOeB2q76toutefois, même si le film est imprégné de culture pulp, il va aussi puiser dans le réservoir du néo modernisme américaine, notamment Thomas Pinchon https://fr.wikipedia.org/wiki/Thomas_Pynchon mais aussi de William S Burroughs https://fr.wikipedia.org/wiki/William_S._Burroughs l'auteur du “Festin Nu” … comme par hasard adapté au cinéma par Cronenberg … avec un certain Peter Weller (wink wink) en 1991 https://fr.wikipedia.org/wiki/Le_Festin_nu_(film) , le monde est petit, non ?Les deux cro-créateurs, geek/nerd/fous furieux de cette époque W.D Richter https://fr.wikipedia.org/wiki/W._D._Richter une vie de scénariste et peu de film et Earl Mac Rauch https://fr.wikipedia.org/wiki/Earl_Mac_Rauch , l'intraverti, mais qui a touché quelques notes sur “New York New York”, en tout ils connaissaient le mouvement néo modernisme, depuis renommé en post modernisme https://fr.wikipedia.org/wiki/Litt%C3%A9rature_postmoderne , parfois pas éloingé des écrits d'un certain Philip K. Dick https://en.wikipedia.org/wiki/Philip_K._Dick dont Dany recommande Le Maitre du Haut Chateau” https://fr.wikipedia.org/wiki/Le_Ma%C3%AEtre_du_Haut_Ch%C3%A2teau en livre ou https://fr.wikipedia.org/wiki/Le_Ma%C3%AEtre_du_Haut_Ch%C3%A2teau_(s%C3%A9rie_t%C3%A9l%C3%A9vis%C3%A9e) dans la petite lucarneMême David Lynch https://fr.wikipedia.org/wiki/David_Lynch est convoqué dans la scène de la prison.Est ce que ce sont les aventures extradimensionnelles foutraques qui ont fait que le film n'a pas marché (spoilers !) et d'ailleurs n'y a til tromperie sur la marchandise, car de 8ème dimension en fait, ne parle pas plutot que prison, à la manière de la Zone Fantôme (coucou les comics DC et les films Superman https://fr.wikipedia.org/wiki/Zone_fant%C3%B4me ) … avec des évadés de cette Dimension … nommés Lectroides https://buckaroobanzai.fandom.com/wiki/Lectroid et inspirés des https://en.wikipedia.org/wiki/Dinosauroid (ceux qui peupleraient la terre s'il un astéroide ne l'avait pas “beugné” y bien longtemps (oui aussi vieux que Dany, Wink Wink… qui vous gratifiera de la dégustation plein micro de menu gateaux, amis misophone, on vous aime !)...Un film qui se sera amusé à savoir si les producteurs regardaient encore les rush notamment dans cette scène demeurée célèbre https://youtu.be/QxjwNpVhknY?si=3zcwQJX2X5AASFps mais il ya une jurisprudence … le cas Powergirl et sa taille de bonnet https://laboitedecomics.wordpress.com/2021/06/05/pourquoi-power-girl-a-des-gros-seins-et-un-grand-decollete/ pour plus d'information…Un scène de moto, qui nous ramène au célèbre tunnel vu dans tant de film le Mt Hollywood (qui en a déroulé de la bobine, dites donc) https://www.imdb.com/search/title/?locations=mount%20hollywood%20dr%20tunnel,%20los%20angeles,%20california,%20usaUn petit tacle au passage à Retour vers Le futur, qui lui a marché …, mais en ayant volé la scène de l'oscillateur de Buckaroo Banzai (convecteur temporel, ça vous dit quelque chose ? Mais aussi à une obscure série (et oui c'est bien le premier d'Entre ! Geek … https://entregeek.lepodcast.fr/entre-geek-fais-comme-chez-toi-avec-causmic-beast ) Expedition Adam '84 (en allemand, “Die Besucher” , parce que … c'est une série Tchècoslovaque … et parce que… et ça vous fera travailler votre allemand… flûte cette phrase pourrait être interprêtée… oupppps) https://fr.wikipedia.org/wiki/Exp%C3%A9dition_Adam_84Back to ze Future… vole même un des seconds rôle qui fait son show en méchant lectroid rouge pas beau… https://www.imdb.com/name/nm0000502/ Christopher Lloyd …. nommmmm de zeuuuuuuus Marty !Et d'ailleurs si nous ouvrons les portes de l'enfer, ou plutôt de IMDB… et ben non retournons au box-office de la sortie de Buckarro … spoiler, il n'avait pas une chance … même si Dany trouve que ce “Last Starfighter“ https://youtu.be/qJb1f847M_Q?si=ZyLDwueYf8xuypqT est un film horrible… l'équipe a été obligée de l'abandonner sur le bord de la route… sacré année que 1984… tiens donc le cinéma ne bégayerait pas en 2024 (Karaté Kid, Indy en 2023…) j'dis ça …Les acteurs donc …● Peter Weller https://www.imdb.com/name/nm0000693/ et notamment la fameuse photo de Carrie Fisher et Peter Weller https://www.reddit.com/r/Robocop/comments/18ec2wg/find_someone_who_looks_at_you_the_way_carrie/ et oui il a bien un doctorat en histoire romaine et enseigne à l'université de Syracuse à New York https://www.ratemyprofessors.com/professor/688885● John Ligthgow https://www.imdb.com/name/nm0001475/ vous l'avez vu partout, de Blow Out https://youtu.be/OhjPbaFquIk?si=yCXemC1CNhY_ZYwL mais aussi l'esprit de Cain https://youtu.be/jx2MeCjfP44?si=lrbKhN0dQblRRzA_ …● 1938 : un feuilleton radio fait par un type qui vend du vin, un certain Orson Welles https://youtu.be/f_rbq3q7IEo?si=DxmUfhIwGdzy7bsC , une certaine guerre des mondes (on est sympa, on vous a mis l'adaptation en français parce que … https://youtu.be/G-tx9ubhDZw?si=FpISQ6rO4oWq3WDE )● Un coup de jus pour se rappeler ses bons moments ? https://youtu.be/cFyL4hsxMvs?si=2TKpZ_YOYzL0zNK- Nirvana avec Christophe Lambert, Eh Eh Eh… (pas merci Babar ! :) )● John Ashton : https://www.imdb.com/name/nm0039226/ là aussi une têete vue partout et qui se plaint dans le flic de Beverly Hills https://www.imdb.com/title/tt0086960/?ref_=nm_ov_bio_lk la même année d'être trop vieux (il a 36 ans !!!!!) et le péché mignon de AK Dallas (oui on lache les dossiers ! )https://youtube.com/playlist?list=PLB_PSRnlpkno2ip9R6xLcDr6T2UDLcQDp&si=hmO42smJwA_wOOqh Duo d'Enfer !!!... Contre recommandé par Dany avec “Timide et sans complexe” https://youtu.be/8UxIugPdTfU?si=veDmSeowxYW7VaJo en 1980 avec un tout Jeune Jeff Goldblum (la vie a trouvé son chemin depuis wink wink) la preuve ici https://www.imdb.com/name/nm0000156/ … Mais AK Dallas répond par une contre contre réco “A nous les petites terriennes” dans la langue de Guillaume Musso et https://youtu.be/-RpxHczcT7Q?si=1CJB_SYjxatoQLI6 “Earth Girls are easy” pour les fans d'extraterrestre au poil soyeux (‘nfin au début) Dany répliquant par un plus consensuel “Série noire pour une nuit blanche” https://youtu.be/E5_rSxcG-R0?si=99hKTU9QPt3ygtyz un film de John Landis… Deux salles, deux ambiances, choisis ton camp poditeurice !!!... D'ailleurs chacun trovera son bonheur en regardant Transylvania 6500 (toujours avec Jeff Goldblum , tiens, tiens ) https://youtu.be/cTJskpL_Bsc?si=f0MUAoQ7wr-85pYX avec un superbe cosplay de Gena Davies en Vampirella (pour plus d'information sur Vampirella , cliquez ici à vos risques et périls, Entre ! Geek niera, etc etc etc >>>>> https://en.wikipedia.org/wiki/Vampirella… Et un coup de Frank Frazetta parce que Dany, encore lui a des livres sur lui https://fr.wikipedia.org/wiki/Frank_Frazetta https://www.noosfere.org/livres/auteur.asp?numauteur=830&Niveau=illus pour certaines illustrations …. musclées :) , voire la celèbre affiche de Mad Max 1 https://www.pinterest.fr/pin/548665167097859088/ et un point Draven Galactifrak https://galactifrak.lepodcast.fr/ https://galacticgallery.com/frazetta/battlestar-galactica-attack-by-frank-frazetta● Tant qu'à faire des “points”, petit point Commando https://youtu.be/tts3Z6Jr58A?si=7Gv-kDeUiR8CwDtX avec Dan Hedaya https://www.imdb.com/name/nm0000445/ ex président crapuleux de la république bananière du film, et qui joue un John Gomez sans couleur et sans odeur, et un morceau de choix dans Alien Resurrection https://www.youtube.com/watch?v=tJD9sFoJ_0k&pp=ygUSYWxpZW4gcmVzdXJyZWN0aW9u● N'oublions pas le role du président joué par Ronald Lacey https://www.imdb.com/name/nm0479951/ , le nazi tortionnaire qui finit comme une bougie dans les Aventuriers de l'Arche Perdue https://youtu.be/YcR9k8o4I0w?si=YSiGiIwnc1GJxstD● Forcément un moment de la caution jeunesse mosellane, Robert Ito https://www.imdb.com/name/nm0411731/ aperçu sur Télé Luxembourg / RTL Télévision dans la série Quincy (oui c'était au siècle dernier) https://youtu.be/GI3pd-dNN-0?si=6DqeiAL0Ycj3xp6o● Pepe Serna, https://www.imdb.com/name/nm0785277/ aperçu dans Scarface (ou il se coupe littéralement en deux … https://youtu.be/439pP_kn76w?si=plqobLnE4_fVGufw et qui, fun fact, dans les scénarios du film joue Reno Nevada (celui qui conte les histoire Buckaroo Banzai, l'alter ego, Earl Mac Rauch lui même)● L'immense Clancy Brown, “Rawhide” dans le film, https://www.imdb.com/name/nm0000317, celui qui nous aura fait le plaisir de bastonner Christophe “Myopie” Lambert dans Highlander (1986 ) https://youtu.be/POU08-vJZ_U?si=QQt3Lc8fch8Qksjt le sergent recruteur de Starship Trooper, un rôle qui ne rate pas sa cible https://youtu.be/B203twyaMfM?si=pA3s_DLo-Jbe0aqI et à revoir dans la série Gen V, spin off de “The Boys” https://www.imdb.com/title/tt13159924/● La caution cheveux peroxydés qui joue Perfect Tommy, Lewis Smith https://www.imdb.com/name/nm0809095 , à jamais dans ce rôle de cosplay de d'un chanteur qui danse avec lui même https://www.youtube.com/watch?v=FG1NrQYXjLU dans un clip réalisé par Tobe Hooper (j'dis ça) Pause technique des neurones proposé par le détourneur de podcast en chef, Dany : Iel existe un.e Buckaroo Banzai dans notre monde, mais qui est iel ???? … allez j'vous aide https://www.lexpress.fr/entrepreneurs/claudie-haignere-quitte-universcience-pour-retourner-a-l-esa_1663666.html (oui je trolle Dany, bisous !) et parce que comme Chris, j'préfère Bernard Lavilliers https://www.youtube.com/watch?v=cOUGL0mG65U (Fensch Vallée represent !!!!)Un moment étrange où on parle de Gena Davies en costume minimaliste https://images.app.goo.gl/mBNBTAy7pUBfDZbp9 et du chat de Babar, faut il y voir une relation …. Bizarre, vous avez dit bizarre ?Le point Dexter (la série, pas le dessin animée” avec Le tueur de la trinité … au marteau https://fr.wikipedia.org/wiki/Saison_4_de_Dexter avec Lithgow mais aussi la saison 5 https://fr.wikipedia.org/wiki/Saison_5_de_Dexter avec Peter Weller et Helen Barkin https://www.imdb.com/name/nm0000289/ (dont hélas, on a peu parlé jusqu'ici) … et là c'est le drame, elle n'a pas joué dans Dexter… nous tenons à nous excuser pour cette méprise … oupppppps :( …. la réalité nous a donné tort …:(Et surtout ne montrez pas Indiana Jones et le temple Maudit à vos enfants … https://youtu.be/W6_tdHbaKeE?si=eCS2B5hZ5XT0Ihok ça abime… Une vidéo https://youtu.be/kNKw8tj_Z5k?si=i1ALQ0nAEHagMRD1 merci Monsieur Bobine qui vous fait le point sur toutes les difficultés du film (de là à dire qu'il vous aurait permis de ne pas écouter ce podcast :) :) :)Et la déclaration de guerre avec la version abrégée https://youtu.be/f6hhVIV_LPs?si=3tX4IpzTjXwc7p8Vallez on arrive près de la fin, tenez bon … avec le défilé des héros … https://youtu.be/8MqJ3iGBdOo?si=J51Kzq2SO8zigujB filmé sur Uptown Girl de Billy Joel, preuve à l'appui https://youtu.be/so6EZrIQZNU?si=2-Sla-G4lNX2UphTUn point costume : le costume de Buckaroo Banzai https://upload.wikimedia.org/wikipedia/en/2/2a/Buckaroo_Banzai_end_credit_cast_walk_scene.jpg a t'il influencé celui de Pee Wee Herman https://en.wikipedia.org/wiki/Pee-wee%27s_Big_Adventure#/media/File:Peeweebigadventure.jpg …. après je pose ça là …. https://www.imdb.com/title/tt0089791/trivia/?item=tr3929065&ref_=ext_shr_lnk Ouuuuuf fini…Merci de votre écoute et à bientôt… Ah ben non, quelle postérité à Buckaroo Banzai ? :● Les jeux vidéos d'actions : Sorti sur ZX Sinclair, Apple II, atari 8b … https://youtu.be/T25PbBHS5-Q?si=k1szoyqVaTbLuG6Q ca ressemblait à ça… minimaliste non ?● Le fameux battlezone tout en fil de fer verdâtre …. https://youtu.be/Ctr54kopo8I?si=i555iw3T48MxOY1G● Pas de Buckaroo Banzai dans Broforce et c'est bine dommage https://youtu.be/HqpfsbqiRCw?si=E4XWBFwWx255zyxx● Mortel Combat, vous avez dit Mortal Kombat 11, ou on entend Peter Weller faire toutes les voix de notre gardien de la paix préféré https://youtu.be/wuAWV6U55PY?si=o3TnrHYI9SHmw5LG parait même qu'il y a eu un Jacky (pardon un Jason) au masque de hockey dans l'opus précédent● Et sinon, si vous avez aimé pousser des figurines (genre BattleTech de Fasa, 1985 https://youtu.be/TLEhw9MmMEI?si=qbBeVP7YdyogmFHl ) et dans les jeux vidéos dérivés Mechwarrior https://en.wikipedia.org/wiki/MechWarrior sensés se passer au XXXIème siècle, un certain docteur B.Buckaroo y sévit https://www.sarna.net/wiki/Team_Banzai● On trouve du Buackaroo dans Star Trek, un vaisseau, tout d'abord https://memory-alpha.fandom.com/wiki/SS_Buckaroo_Banzai mais aussi par l'influence des Okuda mari et femme https://memory-alpha.fandom.com/wiki/Denise_Okuda … elle apparait d'ailleurs dans les bonus du Blu Ray● Et tellement d'information en plus dans le fanzine “Buckaroo Banzai Institute”, en fait plutot prénommé “World Watch ONe” disponible ici https://archive.org/search?query=subject%3A%22buckaroo+banzai%22&and%5B%5D=collection%3A%22bbfanzines%22 entre autre● Même les intellos rigolos s'y sont mis dans “la Vie Aquatique” de Wes Anderson https://youtu.be/cJ2x4gtyNPk?si=CjnZtiyhR_H34gqF&t=75 (ça commence à 1,15mn) La fin se rapproche, tenez bon ● Les suites avortées○ Forcément le film “Buckaroo Banzai Against the World Crime League” … petit ange jamais tourné mais on est passé à coté de ça pour une série en 1998 https://youtu.be/yXluuOWjTms?si=jFzeRKkFIA4s2dHF c'était un mardi pour Buckaroo :)○ Des comics (la liste est longue… heureusement on les trouve en ligne et légalement au moins pour certains https://archive.org/details/buckaroobanzaire0000rauc○ La scène d'ouverture coupée au montage :'( https://youtu.be/uuIzYQnfdpI?si=99X4unf6hFLb_jcF et sa maman (mais chut !)○ Un autre film tout aussi barré et “spoilers” qui n'a pas marché non plus (et scénarisé par WD Richter) “Big Trouble in little China” https://youtu.be/yXluuOWjTms?si=jFzeRKkFIA4s2dHF sans oublié They Live, toujours de Carpenter, (on voit des extraterrestres) https://youtu.be/zLQ2d89vCiw?si=W-HUZXabktAGpfDF● En 2021, voit enfin sortir LE roman Buckaroo Banzai Against the World Crime League, disponible hélas, seulement dans la langue de Buckaroo https://www.goodreads.com/book/show/56656523-buckaroo-banzai-against-the-world-crime-league-et-al … et pour l'avoir terminé récemment, le CausmicBeast du futur de l'enregistrement du podcast peut vous dire que c'est un bouquin exigeant à lire, foutraque … et pour le moins étrange !● La musique qui fait des trous dans la tête !!!!!!! Oui y a des groupes qui s'appellent Buckaroo Banzai en France○ celui de Rouen (début 2000): https://emergencerecords.bandcamp.com/album/hollyweed○ celui d'Evreux (début 2019) :○ https://buckaroobanzai1.bandcamp.com/○ et spécial bonus : un Buckaroo Banzaii de San Diego qui fait de l'électro : https://shaftrecords.bandcamp.com/album/wabi-sabi pas cité dans l'épisode○ Mais n'oublions pas de rendre hommage à Michael Boddicker https://en.wikipedia.org/wiki/Michael_Boddicker petit florilège du film https://www.youtube.com/watch?v=I2EWW3ood3I● Si vous êtes arrivés à la fin de ce très long descriptif d'épisode, n'oubliez pas que vous pouvez envoyer vos remarques à causmicbeast@gmx.fr Bonne position du guetteur aérien à tous, Banzai !!!!!
Dr. Kazu Okuda, Founder, and CEO of Universal Brain, uses neurotyping based on EEG data to better understand the different types of depression and deliver more precise treatments. To facilitate the availability of EEG data, Universal Brain has developed a next-generation EEG headset that is affordable and comfortable. The headset allows for the collection of data that can be used to analyze neural profiles of patients and tailor treatments. This precision psychiatry approach is the future of depression treatment and for identifying early warning signs of depression in the younger population. Kazu explains, "We are using the term neurotyping to solve that kind of problem. Neurotyping is a term we use at Universal Brain, and it's a groundbreaking process of grouping individuals based on brain function measures derived from the EEG data. We'll look at specific reactions of the brain to visual and audio stimuli, which are called event-related potentials, and we are leveraging that kind of brain biomarkers and neurotype the patient based on brain function." "By examining the functioning of the cornea or systems from attention to memory and negative bias and reward function, we aim to reduce the heterogeneity of treatment groups using the brain function biomarkers because depression has a lot of phenotypes. There is no single depression, but we call it depressions because there are tons of variations of combination of the symptoms to meet the criteria of depression. So by neurotyping patients based on brain function, we reduce the heterogeneity of depressions and lead to better outcomes." #UniversalBrain #Neurotyping #BrainBiomarkers #Depression #PrecisionPsychiatry universal-brain.com Listen to the podcast here
Dr. Kazu Okuda, Founder, and CEO of Universal Brain, uses neurotyping based on EEG data to better understand the different types of depression and deliver more precise treatments. To facilitate the availability of EEG data, Universal Brain has developed a next-generation EEG headset that is affordable and comfortable. The headset allows for the collection of data that can be used to analyze neural profiles of patients and tailor treatments. This precision psychiatry approach is the future of depression treatment and for identifying early warning signs of depression in the younger population. Kazu explains, "We are using the term neurotyping to solve that kind of problem. Neurotyping is a term we use at Universal Brain, and it's a groundbreaking process of grouping individuals based on brain function measures derived from the EEG data. We'll look at specific reactions of the brain to visual and audio stimuli, which are called event-related potentials, and we are leveraging that kind of brain biomarkers and neurotype the patient based on brain function." "By examining the functioning of the cornea or systems from attention to memory and negative bias and reward function, we aim to reduce the heterogeneity of treatment groups using the brain function biomarkers because depression has a lot of phenotypes. There is no single depression, but we call it depressions because there are tons of variations of combination of the symptoms to meet the criteria of depression. So by neurotyping patients based on brain function, we reduce the heterogeneity of depressions and lead to better outcomes." #UniversalBrain #Neurotyping #BrainBiomarkers #Depression #PrecisionPsychiatry universal-brain.com Download the transcript here
Okuda x El Eco de LOS40 y un oso gigante en LOS40 Primavera Pop Madrid 2024. Gira OT 2023: ¿Nuevas confirmaciones? 40 cosas sobre Judeline. Entrevista a Caleb Calloway en LOS40 Urban. Conoce los ganadores a la III Edición de los Ondas Globales del Podcast
Okuda x El Eco de LOS40 y un oso gigante en LOS40 Primavera Pop Madrid 2024. Gira OT 2023: ¿Nuevas confirmaciones? 40 cosas sobre Judeline. Entrevista a Caleb Calloway en LOS40 Urban. Conoce los ganadores a la III Edición de los Ondas Globales del Podcast
Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.08.04.551933v1?rss=1 Authors: Muller-McNicoll, M., Zarnack, K., McNicoll, F., Keller, M., Sliskovic, I., Okuda, E. K., Riegger, R. J., Arnold, B. Abstract: Nuclear RNA binding proteins (RBPs) are difficult to study because they often belong to large protein families and form extensive networks of auto- and cross-regulation. They are highly abundant and often localize to condensates with a slow turnover, requiring long depletion times or knockouts that cannot distinguish between direct and indirect or compensatory effects. Here, we developed a system that is optimized for the rapid degradation of nuclear RBPs, called hGRAD. It comes as a 'one-fits-all' plasmid, and integration into any cell line that expresses endogenously GFP-tagged proteins allows an inducible, rapid and complete knockdown. We show that the nuclear RBPs SRSF3, SRSF5, SRRM2 and NONO are completely cleared from nuclear speckles and paraspeckles within two hours. hGRAD works in various cell types, is more efficient than other methods and does not require the expression of exogenous ubiquitin ligases. Combining SRSF5 hGRAD degradation with Nascent-seq uncovered highly dynamic transient transcript changes, compensatory mechanisms and that SRSF5 promotes transcript stability. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC
A document from 1985 written by Mike Okuda addresses no less than the entire look and feel of Star Trek's graphics and the logic of starship display design. This week, we examine a portion of that pitch with the talented Tim Peel, heir apparent to Okuda's work as the director of motion graphics for all Star Trek since Discovery took flight in 2017! See the documents: facebook.com/thetrekfiles Visit the Trekland site for behind-the-scenes access and exclusive merchandise.
A document from 1985 written by Mike Okuda addresses no less than the entire look and feel of Star Trek's graphics and the logic of starship display design. This week, we examine a portion of that pitch with the talented Tim Peel, heir apparent to Okuda's work as the director of motion graphics for all Star Trek since Discovery took flight in 2017! See the documents: facebook.com/thetrekfiles Visit the Trekland site for behind-the-scenes access and exclusive merchandise.
A document from 1985 written by Mike Okuda addresses no less than the entire look and feel of Star Trek's graphics and the logic of starship display design. This week, we examine a portion of that pitch with the talented Tim Peel, heir apparent to Okuda's work as the director of motion graphics for all Star Trek since Discovery took flight in 2017! See the documents: facebook.com/thetrekfiles Visit the Trekland site for behind-the-scenes access and exclusive merchandise.
08 09-05-23 LHDW La historia de un fotógrafo que no puede vender fotos del faro de Ajo, acosado por el entorno de Okuda. Va a ir a juicio por la pérdidas
08 09-05-23 LHDW La historia de un fotógrafo que no puede vender fotos del faro de Ajo, acosado por el entorno de Okuda. Va a ir a juicio por la pérdidas
Welcome back to the Paddle Wheel Podcast. Today, we have a familiar face at Rising Star, but the question is, "Who is JP Okuda?" Sit back and relax as we tee up this Q and A with Rising Star Casino's Golf Pro and find out a little more about him and what's in store for The Links Course this season. #thelinks #casinogolf #risingstarcasino #golfpro #2023golfseason
En "Del Tingo al Tango: Extendido", Edgar Estrada entrevista a las más importantes personalidades del mundo de la cultura...
Edgar Estrada nos cuenta todo sobre el mundo del entretenimiento; espectáculos, cultura, cine, televisión, teatro y muchas recomendaciones a tu alcance. ¡Estamos "Del Tingo al Tango"!Una producción original de Audio Centro
Emotional abuse can be the sneakiest form of abuse because sometimes we're not even sure it's happening. A slightly sarcastic insult, a veiled threat, or a judgment on your intentions, emotional (or"psychological") abuse is harder to detect than physical violence, but can wreak havoc on your mental health for years. In this episode, we describe what emotional abuse is and what are its long term effects. Check out the Emotional Abuse QuestionnaireMcMahon, K., Hoertel, N., Wall, M. M., Okuda, M., Limosin, F., & Blanco, C. (2015). Childhood maltreatment and risk of intimate partner violence: A national study. Journal of psychiatric research, 69, 42-49.For more info, check out: www.alittlehelpforourfriends.comFollow us on Instagram: @ALittleHelpForOurFriends
Are you getting anxious for the golf season to start?
In this interview, Jarrod Jefferies and Deb Tauber interview Dr. Haru Okuda and Dr. Okuda discusses the strategic priorities for the Society of Simulation and Healthcare (SSH). In the show's second part, we highlight the accomplishments of New York City Health and Hospitals. We talk to Dr. Michael Merguerdician, Dana Trottier, and Kimberly Campbell-Taylor. They share their accreditation journey from SSH.
Kali ini Patty merekomendasikan buku self-improvement Hidup Damai Tanpa Berpikir Berlebihan karya Dr Tsuneko Nakamura dan Dr Hiromi Okuda. Buku ini diterbitkan oleh #Gramedia Pustaka Utama Februari 2021 lalu. Dr Tsuneko Nakamura adalah seorang psikiater senior yang ketika buku ini pertama kali rilis 2018 lalu berusia 89 tahun. Lewat buku ini, kita diajak untuk mengetahui perjalanan hidup Dr Tsuneko dan cara dia memandang setiap situasi dalam hidup yang membuatnya bisa menjalani segala rintangan dan tantangan dengan pola pikir yang begitu menenangkan. - Kunjungi channel Youtube Podluck Podcast Collective: https://www.youtube.com/podluckpodcastnetwork Follow media sosial Podluck Podcast: https://www.instagram.com/podluckpodcast https://www.twitter.com/podcastpodluck
Olá, olá pessoal! Chegando com um episódio especial do podcast Beisebol Mundo Afora! Neste encontro conversamos com Pedro Okuda, técnico da Seleção Brasileira Softbol, e também com a atleta Hitomi Nakae. Eles analisaram como foi a disputa do Panamericano de Softbol na Guatemala e também contaram um pouco sobre a experiência no país. Ouve aí, nosso papo ficou bem legal. Vem conferir :) Participantes Everton Vasconcelos (@evasconcelos__) Luiz Eduardo Mouta (@lesmouta) Pedro Okuda (poksilva44) Hitomi Nakae (hitomi.nakae) Arte de divulgação Isabel Ferreira (@ibaselfes) Siga @beisebolmundoafora no Instagram!
Olá, olá pessoal! Chegando com mais um episódio do podcast Beisebol Mundo Afora. No episódio de hoje, recebemos Pedro Ivo Okuda, terceira base do Marília e da seleção brasileira de beisebol. Além de jogador, Okuda também é técnico da seleção feminina de softbol. O nosso papo ficou bem legal, dá o play e vem conferir :) Participantes Everton Vasconcelos (@evasconcelos__) Felipe Martins (@hashtagtuts) Luiz Eduardo Mouta (lesmouta) Pedro Okuda (poksilva44) Arte de divulgação Isabel Ferreira (@ibaselfes) Nossa campanha no apoia-se: apoia.se/beisebolmafora Siga @beisebolmundoafora no Instagram!
Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Darin T. Okuda, MD, professor of neurology and director of Neuroinnovation and the Multiple Sclerosis & Neuroimmunology Imaging Program at The University of Texas Southwestern Medical Center at Dallas; and Karin Cook, senior vice president of medical strategy and clinical ethnographer, Heartbeat Medical Communications. The pair spoke about their research into the wasted costs associated with disease-modifying therapies (DMTs) for patients with multiple sclerosis, what they've observed at their center, the wide-reaching impact of this waste on the healthcare continuum, and the future solutions that are being worked on for this problem. Click here for more coverage of this story: Multiple Sclerosis DMT Waste Is Staggering, New Study Shows Wasted DMTs in Dr. Okuda's office [Image] Episode Breakdown: 1:45 – Background on the study conducted by Okuda et al. 4:05 – Perspective on the cost driven by DMT waste 6:30 – Current landscape of prescriptions and adherence in MS 8:35 – Disparities in MS treatment adherence 11:00 – The link to the physician-patient relationship 16:40 – The process of choosing a DMT and shared decision-making 23:00 – Neurology News Minute 25:45 – Finding solutions to the DMT waste problem 33:40 – The role of the individual neurologist and patient 38:30 – Access to specialist care and resources 42:40 – Building trust with patients and general medical mistrust 47:00 – Next steps and closing thoughts This episode is brought to you by the Medical World News streaming service. Check out new content and shows every day, only at medicalworldnews.com The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Zonisamide Oral Suspension FDA-Approved for Partial Seizures in Epilepsy FT218 Receives Tentative Approval for EDS, Cataplexy in Adults With Narcolepsy FDA Clears Rapid Hyperdensity Tool for Inclusion in RapidAI Platform for Neurovascular Conditions ALS Therapy Tofersen Has NDA Accepted by FDA, Granted Priority Review Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCE 1. Okuda DT, Burgess KW, Cook K, McCreary M, Winkler MD, Moog TM. Hiding in plain sight: the magnitude of unused disease-modifying therapies in multiple sclerosis and strategies for reducing the economic burden. Mult Scler Relat Disord. 2022;63:103920. doi:10.1016/j.msard.2022.103920
Repasamos en este programa los cuatro temas de la semana. Comenzamos dándole a la memoria recordando cómo fue el año 2006. Seguimos con una forma: redonda, con un color, el rojo, y el medio un verbo: merecer. Un verbo que nos dio para tanto que todavía seguimos dándole vueltas. Además, tres gatopardos que escuchar: el director y guionista Juan Luis borra, el artista Okuda y la periodista Mamen Mendizábal.
El artista urbano, reconocido mundialmente por sus coloridas obras, ha visitado El Faro de Mara Torres y ha recorrido junto a ella algunos de sus proyectos más espectaculares
El artista urbano, reconocido mundialmente por sus coloridas obras, ha visitado El Faro de Mara Torres y ha recorrido junto a ella algunos de sus proyectos más espectaculares
El artista urbano, reconocido mundialmente por sus coloridas obras, ha visitado El Faro de Mara Torres y ha recorrido junto a ella algunos de sus proyectos más espectaculares
In this episode, we chat with Cheryl Okuda. Cheryl Okuda is a professional dancer, educator, facilitator of anti-racism, early childhood education specialist and mother. She is the co-founder of Pokuda, a resource for multicultural support for young learners, centering social-emotional learning. Cheryl aspires to continue preparing new educators, while continuing to create and teach within her dance community. Follow Cheryl on Instagram at @smallvoicesbigideas and visit her website to learn more about her online learning programming. Be sure to also follow Pokuda @pokuda_ to connect on anti-racism, early childhood, and social-emotional learning support. Follow us @MindfulGrooving, Brittany @BrittanyHarlin and Sara @GoodStuffSara. For more Egun Artist Productions, visit our website. Be sure to LEAVE US A VOICEMAIL and let us know what's on your mind! More About Cheryl: Cheryl Okuda began her dance training at the age of seven and has trained in ballet, tap, jazz, contemporary, modern, pointe, musical theater, and hip-hop. Cheryl has earned many awards for her dancing and choreography in several Midwest Competitions throughout the Chicagoland area. She has a minor in dance from Columbia College and was a proud company member of Boom Crack! Dance Company for 10 years. While dance and choreography will always be a passion of hers and something she continues to develop, teaching is Cherylʼs true calling. In addition to teaching dance, Cheryl holds a degree in Early Childhood Education and has been a preschool teacher for over 7 years. She is a co-founder of Pokuda, an organization dedicated to anti-biased education. She is also the founder of Small Voices Big Ideas, an online tutoring service specializing in Early Childhood Social-Emotional Skills. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/mindfulgrooving/message
Haru Okuda, MD, FACEP, FSSHExecutive Director, Center of Advanced Medical Learning and Simulation Associate Vice President Interprofessional Education and PracticeChief Executive Officer, Health Professions Conferencing Corporation University of South Florida Health Dr. Okuda is the Executive Director and CEO of USF Health's Center for Advanced Medical Learning and Simulation (CAMLS), Health Professions Conferencing Corporation (HPCC). In this role, he has oversight of a 90,000 ft2 state of the art, advanced training facility, with the mission of creating and providing experiential learning that improves clinical skills and patient care in the community and around the globe. In addition to this role, Dr. Okuda also serves as USF Health's Associate Vice President of the Office of Interprofessional Education and Practice (https://health.usf.edu/ipep) focused on creating interprofessional learning opportunities from early healthcare training to clinical practice. He is Professor at the Morsani College of Medicine and practices clinically in the emergency department at Tampa General Hospital. Prior to coming to USF Health, Dr. Okuda was the national medical director for the Simulation Learning Education and Research Network (SimLEARN) where he established national strategy and business plans for simulation-based programs at more than 150 U.S. Department of Veteran Affairs' medical facilities. In addition to his role as national medical director of SimLEARN, Dr. Okuda served as the acting deputy chief of patient care services officer for the Veteran's Health Administration, where he was responsible for policy development and oversight of the national Office for Women's Health Care, Community and Preventative Health, Social Work and Pharmacy Benefits Management. Before joining the VA, he was assistant vice president and director of the Institute for Medical Simulation and Advanced Learning for the New York City Health and Hospitals Corporation, the largest public health system in the United States. Dr. Okuda received his Bachelor of Science degree in neuroscience from Brown University, his medical degree from New York Medical College, and his certificate in Healthcare Modeling and Simulation from the Naval Postgraduate School in California. He completed a residency in emergency medicine at the Icahn School of Medicine at Mount Sinai where he served as their chief resident, and then completed a clinical quality fellowship from the Greater New York Hospital Association. He is a fellow of the American College of Emergency Physicians and an inaugural fellow of the Society for Simulation in Healthcare Academy. He has also served as a chair or member of several medical and simulation committees; and most recently serves as President for the Society for Simulation in Healthcare. He has co-authored numerous textbooks, peer-reviewed publications and textbook chapters. Known for his passion for teaching, innovation and business, Dr. Okuda received the 2017 Distinguished Educator Award by the Society for Academic Emergency Medicine Simulation Academy for the creation of the simulation-based training program SimWARSTM; was named one of the top 25 Healthcare Leaders Under 40 by Becker's Hospital Review in 2012; was selected as one of 40 Under 40 New York's Rising Stars in Business by Crain's NY Business Magazine in 2011; and was awarded the 2017 Healthcare and Medicine Leader of the Year by i4 Business Magazine.
Steve Spohn sits down with talented actress Amy Okuda to discuss how to give up control when you're facing your fears, and how to capitalize on success when it knocks on your door.
08 27-10-20 LHDW Visita de Jose e la Hoz, ex alcalde de Bareyo (Ajo) y responsable de la obra del faro de Okuda
01 11-06-20 LHDW Mi opinión sobre la polémica de Okuda y el Faro de Ajo
02 10-06-20 LHDW Polémicas declaraciones de Okuda ¿te parece bien que pinten un Faro que es patrimonio?
For Okuda San Miguel, his art is his church. And a church is just another canvas--literally. Okuda uses geometric shapes and vibrant colors to bring new life to forgotten buildings and overlooked walls all across the world, often splashing in references to classical art or figures from his own life. Listen to this episode of The Cultured Podcast to hear what famous painting Okuda regularly visits and how he continues to draw inspiration from this piece in his work. Visit culturedpodcast.com for full transcripts of this episode and links to things mentioned.
© 2020-2026 Ivy Podcast Discovery LLC
